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Beclin 1 is a mammalian autophagy protein and has important functions in 
development, tumor suppression and neurodegeneration. Beclin 1 exists in a protein 
complex with Vps34, which is a class III phosphatidylinositol (PtdIns) 3-kinase and 
mediates multiple vesicle trafficking pathways including autophagy and endocytosis. 
However the precise role of Beclin 1 in autophagy regulation is not well understood and 
information is lacking regarding the function of Beclin 1 in neuronal development and 
degeneration. In a study that combines mouse genetics and biochemistry, three novel 
Beclin 1 interaction proteins Atg14L (yeast Atg14-like), Rubicon (RUN domain and 
cysteine-rich domain containing, Beclin 1-interacting protein) and Nrbf2 were identified 
from mouse tissues. Gel filtration and co-immunoprecipitation show that these proteins 
co-exist in one large in vivo protein complex, from which multiple sub-complexes may be 
generated. Functional assays reveal that Atg14L positively regulates Vps34/PtdIns3K 
kinase activity and autophagy while Rubicon shows negative regulatory effects. 
Moreover, Beclin 1 and Atg14L synergistically promote autophagosome biogenesis while 
over-expression of Rubicon causes formation of aberrant late endosomes/early lysosomes 
and blocks autophagosome maturation. Therefore Atg14L and Rubicon regulate 
autophagy in opposite directions and at different steps, possibly through forming 
distinctive complexes with Beclin 1 and mediating Vps34/PtdIns3K kinase activity.  
Meanwhile, to study the function of Beclin 1 in neuronal development and degeneration, 
targeted deletion of beclin 1 was performed in pyramidal cells of the hippocampus and 
the cerebral cortex and in cerebellar Purkinje cells. Consequently, the deletion leads to 
rapid and severe degeneration in these cells. In degenerating pyramidal cells, there is 
intracellular protein accumulation that may have resulted from impaired autophagy, and 
activation of apoptotic pathway is also observed. In Purkinje cells, electron microscopy 
studies show a large number of aberrant electron dense structures and they are closely 
associated with intracellular membranes. Meanwhile, immuno-staining shows that 
deletion of beclin 1 induces localization change of PtdIns(3)P, the product of 
Vps34/PtdIns3K. Therefore it is suggested that Beclin 1 is critical for normal neuronal 
development and that its deletion not only results in impaired autophagy but also may 
induce abnormal membrane and vesicle trafficking, possibly due to disrupted regulation 
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Chapter I  
Introduction  
 
1.1 Autophagy       
The balance between protein synthesis and degradation is important for normal 
function and survival of cells. While the ubiquitin-proteasome pathway is responsible for 
specific clearance of short-lived proteins, long-lived proteins are delivered to lysosomes 
by autophagy, which is the major inducible pathway for general turnover of bulk 
cytoplasmic components including entire organelles such as mitochondria (Klionsky and 
Emr, 2000; Levine and Klionsky, 2004; Levine and Kroemer, 2008). There are three 
types of autophagy: macroautophagy, microautophagy, and chaperone-mediated 
autophagy. In microautophagy, cytosolic components are directly engulfed by lysosomal 
limiting membrane at lysosome surface (Uttenweiler and Mayer, 2008), while in 
chaperone-mediated autophagy, specific cytosolic proteins with certain motif structures 
are degraded through chaperone complexes both in the cytocol and associated with 
lysosomal membranes (Massey et al., 2006). Macroautophagy is the most widely studied 
type of autophagy among these three types, and is usually referred to as autophagy. The 
initial step of autophagy is the synthesis of de novo single membrane sac named isolation 
membrane, which fuses at the edges and thereby enwraps cytosolic proteins and 
organelles into a double-membrane structure called autophagosome. The outer membrane 
of autophagosomes finally fuses with the membrane of lysosomes, releasing the inner 
membrane and the content for hydrolytic enzyme mediated degradation in lysosomes. 
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Although the morphology of autophagy has been widely studied in animal cells, the 
molecular mechanism was poorly understood, until a screening experiment was 
performed in the budding yeast Saccharomyces cerevisiae. In yeast, autophagy is induced 
by nitrogen deprivation. The vacuoles generated in response to starvation, which are 
equal to autophagosomes in mammalian cells, can be easily monitored by light 
microscopy. From screening for mutant yeast cells in which autophagic vacuoles do not 
accumulate under starvation conditions and as a result bulk protein degradation, 
sporulation and cell viability are affected, fifteen autophagy-related (Atg) genes were 
identified and later a few more were discovered (Tsukada and Ohsumi, 1993; Klionsky et 
al., 2003). Almost all of these Atg genes have orthologs in higher eukaryotic cells such as 
mammalian cells, suggesting that the machinery of autophagy is well conserved.  
 
1.2 Two ubiquitin-like conjugation systems    
Autophagy starts from autophagosome formation, and two ubiquitin-like 
conjugation systems are important for this initial step. One is Atg5-Atg12 system 
(Mizushima et al., 1998b). Atg12p forms a conjugate with Atg5p via a covalent bond 
between the carboxy-terminal glysine of Atg12p and a lysine of Atg5p at residue 149. 
This conjugation reaction is mediated by two other Atg proteins, Atg7p and Atg10p. 
Apg7 shows significant homology to the ubiquitin activating enzyme (E1) (Tanida et al., 
1999), and Apg10p is considered to be a ubiquitin conjugating enzyme (E2)-like protein 
(Nemoto et al., 2003). Finally, another protein, Atg16p, binds to the conjugated Atg5p 
and oligomerizes to link a pair of Atg12p-Atg5p conjugates to form a complex 
(Mizushima et al., 1999; Kuma et al., 2002). Similar conjugation was also found in 
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human cells (Mizushima et al., 1998a) so it is highly conserved. In mammalian cells, 
Apg5p-Apg12p conjugates localize on the isolation membrane and dissociate upon 
autophagosome formation, therefore it is essential for the autophagosomal precursors to 
form. 
Another ubiquitin-like modification that is important for initiation of autophagy is 
the processing of Atg8p, and in this process, Atg7p and Atg3p act as E1 and E2 like 
enzymes respectively (Ichimura et al., 2000). Unlike Atg12p, Atg8p is finally conjugated 
to phosphatidylethanolamine (PE), and it must first undergo a series of posttranslational 
modification before it finally associates to the autophagosome membrane. A critical step 
is a proteolytic cleavage of the C terminal of Apg8p, removing the arginine residue from 
the nascent Atg8p precursor to expose a conserved glysine residue, and this step is 
catalyzed by a constitutively expressed cysteine protease, Atg4p. 
LC3 (microtubule-associated protein 1 (MAP1) light chain 3), the mammalian 
orthologue of Atg8, is the first mammalian autophagy gene identified to be associated 
specifically to the autophagosome membrane. Therefore, it can be used as a molecular 
marker for the autophagic membrane (Kabeya et al., 2000). In vivo studies using a GFP-
LC3 tansgenic mouse reveal that under starvation conditions, increased numbers of 
punctate dots are observed in most tissues, indicating the induction of autophagy 
(Mizushima et al., 2004). Targeting of LC3 to the isolation membrane also requires Atg5-
Atg12 conjugate, as is shown by a study using Atg5-deficient mouse embryonic stem 
cells (Mizushima et al., 2001). 
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Two ubiquitin-like systems are required for autophagy. (a) The ubiquitin system. (b) The Atg12-Atg5 
system. (c) The Atg8 system. (From Ohsumi Y, Nature Reviews Molecular Cell Biology, 2001) 
 
1.3 Beclin 1      
Another protein that is important for autophagy induction and yet has distinct 
function from the two ubiquitin-like conjugation systems is Beclin 1. Beclin 1 is the 
mammalian ortholog of yeast gene Atg6/Vps30, and is one of the first identified 
mammalian orthologs of Atg genes. 
In yeast, Atg6 is identical to Vps30, one of vacuolar protein sorting (VPS) genes 
that are required for correct targeting of soluble hydrolases from late-Golgi to vacuoles 
(Horazdovsky et al., 1995). Atg6p/Vps30p exists in two distinctive protein complexes 
that both contain Vps34p, a phosphoinositide 3-kinase (PI3K), and its activator Vps15p. 
One Atg6p/Vps30p complex contains Atg14p and is essential for autophagy induction, 
and the other contains Vps38p and functions in vacuolar protein carboxypeptidase Y 
(CPY) sorting pathway that delivers CPY and other vacuolar proteins from the late Golgi 
to the vacuole (Kametaka et al., 1998; Kihara et al., 2001b). Atg14 mutants exhibit 
defective autophagy but display normal CPY sorting, and the over production of Atg14p 
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partially reverses the autophagy defect induced by Atg6/Vps30 mutation but has no effect 
on CPY sorting defect (Kametaka et al., 1998). Meanwhile, Vps38 mutants exhibit 
disrupted CPY sorting but intact autophagy levels. Moreover, Atg14p and Vps38p do not 
co-immunoprecipitate. Therefore, the Atg14p containing and Vps38p containing 
Atg6p/Vps30p-Vps34p-Vps15p complexes are two distinctive complexes and function 
separately, and Atg6p/Vps30p is unique and different from other Atg proteins in that it is 
not required for autophagy alone. Given the fact that loss of Atg38 dramatically disruptes 
interaction between Atg6p/Vps30p and Vps34p-Vps15p while deletion of Atg14 has little 
effect, it is estimated that Vps38p containing complex is much more abundant in yeast 
cells (Kihara et al., 2001b).   
 
 
Model for two distinct Atg6p/Vps30p-Vps34p-Vps15p complexes (from Kihara et al., 2001) 
 
 
In yeast, several autophagy proteins, including Atg5p, Atg16p and Atg8p that 
reside on autophagosome membrane, and Atg1p, a kinase functioning in autophagosome 
formation, are all localized on perivacuolar structures prior to autophagosome formation. 
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These structures were named pre-autophagosomal structures (PASs) and both 
Atg6/Vps30p and Atg14p are important for delivering other Atg proteins from cytosol to 
PASs (Kihara et al., 2001b; Suzuki et al., 2001).  
In mammalian cells Beclin 1 was first identified as a novel coiled-coil protein that 
interacts with cell death inhibitor Bcl-2 through a yeast two-hybrid screen using an adult 
mouse brain library. From deletion mutation analysis it is estimated that the putative Bcl-
2 binding domain is localized at the N-terminus of the protein, while the BH1 domain in 
Bcl-2 is responsible for its interaction with Beclin 1 (Liang et al., 1998). Recently Beclin 
1 was further shown to be a Bcl-2-homology-3 (BH3)-only protein (Maiuri et al., 2007; 
Oberstein et al., 2007). Beclin 1 is mono-allelically deleted in a high percentage of 
human breast, ovarian and prostate carcinomas (Aita et al., 1999), and its gene transfer 
inhibits cell growth in human breast cancer cell line as well as tumorigenesis in nude 
mice (Liang et al., 1999). Therefore Beclin 1 is considered a haploinsufficient tumor 
suppressor gene in mammals. Moreover, homozygous targeted disruption of beclin1 in 
mice caused the mice to die between embryonic day 7.5 (E7.5) and E8.5, indicating that 
Beclin 1 is important for embryonic development, and heterozygous disruption results in 
increased spontaneous tumorigenesis (Qu et al., 2003; Yue et al., 2003).  
Like yeast Atg6p/Vps30p, Beclin 1 also mediates autophagy in mammalian cells. 
Transformation of beclin 1 into Atg6/Vps30-disrupted yeast restored the autophagy to 
normal levels, and transfer of beclin 1 gene into MCF7 human breast carcinoma cells that 
do not express detectable levels of endogenous Beclin 1 increased the autophagy levels 
after serum and amino-acid deprivation (Liang et al., 1999). Beclin 1-/- ES cells show 
defect in nutrient deprivation induced autophagy but no significant changes in apoptosis 
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(Yue et al., 2003), and Beclin 1+/- mice show reduced autophagy levels in tissues (Qu et 
al., 2003; Yue et al., 2003). Therefore the function of Atg6p/Beclin 1 in autophagy is well 
conserved. 
 
1.4 Vps34/PtdIns3K and its function in regulation of autophagy 
In mammalian cells, quantitative analyses show that Beclin 1 localizes both in 
cytosol and on membranes, and that all Beclin 1 is associated with Vps34/PtdIns3K, a 
type III phosphoinositide 3 (PI 3)-kinase that generates phosphotidylinositol 3-phosphate 
(PtdIns(3)P) from the substrate phosphatidylinositol (PI) (Schu et al., 1993; Kihara et al., 
2001a). The Beclin 1-Vps34/PtdIns3K complex localizes to the trans-Golgi network 
(TGN) , and Vps34/PtdIns3K is recruited from the cytosol to the membrane and is 
activated by its activator Vps15p, which is a membrane associated serine/threonine 
protein kinase that helps activate the PI 3-kinase activity of Vps34/PtdIns3K (Stack et al., 
1993; Stack et al., 1995). 
Vps34/PtdIns3K functions in multiple vesicle trafficking pathways including 
endocytosis and is also essential for autophagy induction (Simonsen et al., 2001; Lindmo 
and Stenmark, 2006). Deletion of Vps34p in yeast disrupts starvation induced autophagy 
(Kihara et al., 2001b), and in HT-29 human colon cancer cells treatment with PI 3-kinase 
inhibitors wortmannin, LY294002 or 3-methyladenie (3-MA), as well as down-regulation 
of Vps34/PtdIns3K, inhibits autophagy. In contrast, adding Vps34/PtdIns3K product 
PtdIns(3)P to the cells promotes autophagy (Petiot et al., 2000). Among the PI 3-kinase 
inhibitors, 3-MA preferentially inhibits class III PI 3-kinases and is widely used as an 
inhibitor of autophagy. 
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Like in yeast, the function of Beclin 1-Vps34/PtdIns3K complex in the regulation 
of autophagy is likely to be at the initial step of autophagy induction. With Beclin 1, 
Vps34/PtdIns3K participates in the nucleation of autophagosome formation, and also 
mediates localization of other autophagy proteins to the preautophagosomal structure 
(PAS) (Kihara et al., 2001b; Suzuki et al., 2001). The dynamic membrane trafficking 
mediated by Vps34/PtdIns3K complex is important for autophagy induction.  
The Vps34/PtdIns3K product PtdIns(3)P has several known protein effectors that 
have specific domains. The first identified PtdIns(3)P binding domain is FYVE (for 
conserved in Fab1, YOTB, Vac1 and EEA1) zinc finger domain (Stenmark et al., 2002), 
and another one is conserved Phox-homology (PX) domain (Ellson et al., 2002). From 
their specific binding to PtdIns(3)P, these domains can be used as probes to study the 
localization of PtdIns(3)P.    
Although Beclin 1 is essential for regulatory function of Vps34/PtdIns3K on 
autophagy it is not necessary for the other function of Vps34/PtdIns3K on protein 
trafficking. Forced expression of beclin 1 in yeast strains that are deficient in Atg6/Vps30 
does not rescue the disrupted CPY sorting pathway (Liang et al., 1999). Furthermore, 
knockdown of Beclin 1 in mammalian cells does not affect the lysosomal enzyme sorting 
and protein trafficking in the endocytic pathway (Zeng et al., 2006).  
 
1.5 Pro-survival or pro-death? 
It has long been debated what the function of autophagy is in cell death, and in 
yeast it is considered that autophagy generally functions in favor of cell survival under 
stressful conditions such as starvation. Yeast with Atg gene mutations fail to initiate 
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autophagy and die under starvation conditions (Tsukada and Ohsumi, 1993; Klionsky et 
al., 2003). Evidence supports that this is also true in other species because in autophagy, 
cytoplasm components are degraded to generate an internal reserve of nutrients, and 
amino acids from lysosomal degradation can be used as energy source and for novel 
protein synthesis.  
In the nematode Caenorhabditis elegans, in order to survive unfavorable 
environment such as food limitation or increased temperature, C elegans enter dauer, a 
stage of developmental arrest. Animals that carry a loss of function mutation in insulin-
like tyrosine kinase receptor daf-2 show constitutive entry into dauer at 25°C and 
extended adult life-span at lower temperatures. When the expression of bec-1, the C. 
elegans ortholog of Atg6/Vps30, was inhibited with RNA interference (RNAi), animals 
showed abnormal dauer morphogenesis and died within a few days at 25°C. Treatment 
with bec-1 RNAi also reduced the extension of life-span of daf-2 mutant animals. RNAi 
treatment targeting other autophagy genes induced similar phenotypes, indicating that 
autophagy genes are important for dauer morphogenesis and life-span extension in C. 
elegans (Melendez et al., 2003). In the fruitfly Drosophila melanogaster, the fat body 
formed during the larval period functions as a sensor for nutritional levels. Starvation 
induces a significant increase in the level of autophagy in the fat body, and either larva 
ubiquitous or fat body targeted inhibition of autophagy with RNAi against Drosophila 
ortholog of Atg5 resulted in reduced larva or cell size (Rusten et al., 2004; Scott et al., 
2004). In mammalian cells, when primary cells or immortalized interleukin-3 (IL-3) 
dependent cells generated from the bone marrow of Bax/Bak double knockout mice (in 
which deletion of the two pro-apoptotic members of the Bcl-2 family makes the cells 
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resistance to apoptosis) are deprived of IL-3, cells are not able to utilize the nutrients in 
the extracellular media and activate autophagy to degrade intracellular contents for ATP 
production and survival maintenance. Treatment of IL-3 deprived cells with either small 
hairpin RNA (shRNA) against autophagy gene Atg5 or Atg7, or with an autophagy 
inhibitor, induces cell death. This can be reversed by supplying the cells with alternative 
metabolic substrate for oxidative phosphorylation at mitochondria to make up for the loss 
of autophagy. This indicates that in the situation of growth factor withdraw autophagy 
functions to maintain cell survival (Lum et al., 2005). Furthermore, the autophagy level 
in mice is low during embryogenesis but is transiently activated after birth to maintain 
adequate amino acid levels so as to combat the nutrient limitation that neonates face. 
Mice deficient in either Atg5 or Atg7 are defective in autophagy and die within one day 
after delivery, showing reduced amino acid levels in tissues and signs of energy depletion. 
This suggests that autophagy in essential for mammalian survival during neonatal 
starvation (Kuma et al., 2004; Komatsu et al., 2005). In conclusion, from yeast to 
mammalian cells conserved autophagy is induced to maintain cell and animal survival in 
stressful conditions such as starvation.  
In some other cases, autophagy constitutes a pathway that contributes to cell death, 
possibly through excessive self-digestion. This pathway is called autophagic cell death or 
type II programmed cell death, in contrast to apoptosis or type I programmed cell death. 
In a number of mammalian cell lines, treatment with the caspase inhibitor (O-methyl)-
fluoro-methylketone (zVAD) induces non-apoptotic cell death that shows characteristics 
of autophagy, and the cell death can be blocked with either the autophagy inhibitor 3-MA 
or wortmannin, or by knockdown of autophagy gene Atg7 or beclin 1 (Yu et al., 2004). 
 11
Moreover in Bax-/-/Bak-/- mouse embryonic fibroblast cells, apoptotic death stimulation 
induces non-apoptotic cell death that exhibits autophagy induction, and this cell death can 
be suppressed with autophagy inhibitor treatment. It is also dependent on autophagy 
proteins Atg5 and Beclin 1 (Shimizu et al., 2004). In addition, in human cervical 
carcinoma Hela cells, Atg5 interacts with Fas-associated protein with death domain 
(FADD) to contribute to autophagic cell death,  which can be inhibited with Atg5 
knockdown or 3-MA treatment (Pyo et al., 2005). Therefore autophagy may function in 
both directions, to maintain cell survival and to mediate cell death, depending on the 
context. 
 
1.6 The complex role of Beclin 1 in autophagy and apoptosis 
As the possible contributing force to type II programmed cell death, autophagy 
has complex crosstalk with type I programmed cell death (apoptosis), and one intriguing 
function of Beclin 1 is its coordination of autophagy and apoptosis. Beclin 1 was first 
identified as interaction protein of Bcl-2, and it contains a BH3 domain that is both 
necessary and sufficient for its interaction with Bcl-XL, both of which are members of the 
Bcl-2 family that have pro-survival functions in the apoptotic pathway (Maiuri et al., 
2007; Oberstein et al., 2007). The interaction between Beclin 1 and Bcl-2 may occur on 
outer membranes of mitochondria or endoplasmic reticulum (ER), and forced expression 
of ER-targeted Bcl-2 inhibits binding of Beclin 1 to Vps34/PtdIns3K as well as Beclin 1 
dependent autophagy while Beclin 1 mutants that cannot bind to Bcl-2 induce excess 
level of autophagy (Pattingre et al., 2005). Meanwhile, treatment of cells with BH3-
mimetic compound ABT737, which inhibits the Beclin 1-Bcl-2/ Bcl-XL interaction in a 
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competitive manner, stimulates Beclin 1-dependent autophagy (Maiuri et al., 2007). 
Furthermore, Bcl-2 down-regulation in human leukemic HL60 cells with expression of 
antisense message induces massive cell death accompanied with activated autophagy 
(Saeki et al., 2000). Therefore, Bcl-2 and other apoptotic proteins have regulatory effect 
on autophagy and this occurs through interaction with Beclin 1. 
Change in autophagy levels can also affect apoptosis. In fact inhibition of 
autophagy often leads to activation of apoptosis. In C elegans,  the Beclin 1 ortholog 
BEC-1 forms a complex with Bcl-2 ortholog CED-9, and disruption of bec-1 induced 
apoptosis (Takacs-Vellai et al., 2005). In nutrient depleted mammalian cells, inhibition of 
autophagy either with siRNA targeting critical Atg genes including beclin 1 or with 
chemical autophagy inhibitors often leads to cell death that is dependent on mitochondrial 
outer membrane permeabilization and caspase activation and is therefore apoptotic (Boya 
et al., 2005). Similarly, inactivation of LAMP2 by RNAi inhibits fusion of 
autophagosomes with lysosomes, and induces accumulation of autophagosomes under 
starvation that is followed by cell death with features of apoptosis (Gonzalez-Polo et al., 
2005). 
Reagents that inhibit apoptosis can also induce autophagy. Treatment of HL-60 
human myeloid leukemian cells with vitamin D3 inhibits apoptosis but induces 
autophagy, possibly through up-regulation of Beclin 1 and Vps34/PtdIns3K protein levels 
(Wang et al., 2008).  
In summary, in response to various stimuli, autophagy and apoptosis are 
selectively induced in cells, and altering one pathway often leads to changes in the other. 
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Beclin 1 may be the key protein in coordinating the two pathways through forming 
different protein complexes with different interaction partners.  
 
 
The relationship between apoptosis and autophagy (From Maiuri M et al., Nature Reviews Molecular 
Cell Biology, 2007) 
 
1.7 Beclin 1 interacting proteins 
In addition to Bcl-2 and Vps34/PtdIns3K, recently several novel Beclin 1 
interaction proteins have been identified. UV irradiation resistance-associated gene 
(UVRAG) was identified as a protein that immunoprecipitated with Bcl-2-Beclin 1-
Vps34/PtdIns3K multiprotein complex. It binds directly to Beclin 1 through the coiled-
coil domains in itself and in Beclin 1, and they interdependently promote autophagy and 
induce autophasosome formation, possibly thorough positive regulation of 
Vps34/PtdIns3K lipid kinase activity by UVRAG. Like beclin 1, UVRAG is also 
monoallelically deleted in various human cancers, and ectopic expression of UVRAG in 
one type of these cells (human colon cancer HCT116 cells) suppresses cell proliferation 
and inhibits tumorigenicity of the cells (Liang et al., 2006). Bif 1, originally discovered as 
a Bax-binding protein that localizes on intracellular membranes, was shown to form a 
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complex with Beclin 1. This interaction is thought to be bridged by UVRAG, through 
binding between the C-terminal SH3 domain of Bif1 and UVRAG, and like UVRAG, 
Bif-1 also positively regulates Vps34/PtdIns3K lipid kinase activity and autophagy 
(Takahashi et al., 2007). Ambra1 (activating molecule in Beclin 1-regulated autophagy) is 
a gene involved in nervous system development that was isolated from a large-scale 
mutagenesis approach. Homozygous disruption of Ambra1 induces neural tube defects, 
unbalance cell proliferation and excessive apoptosis. Yeast two-hybrid screening with a 
portion of Ambra1 identified Beclin 1, suggesting that Ambra1 is also a Beclin 1 
interaction protein, and Ambra1 o positively regulates autophagy. Consistent with this 
function, Ambra1 deficient embryos show severe defect in autophagy and accumulation 
of ubiquitinated proteins (Fimia et al., 2007).  
However, despite the recent discoveries, the exact role of Beclin 1 in autophagy 
regulation and its autophagy unrelated functions still remain to be characterized. 
Although yeast Atg6/Vps30p forms two distinctive complexes that have different 
functions, it is not known how many Beclin 1-containing protein complexes mammalian 
cells possess and the composition of the complex(es). Furthermore the molecular 
mechanism underlying the function of Beclin 1 in autophagy regulation still remains 
unknown. Unlike atg5-/- and atg7-/- mice that are born almost normally and then die 
within one day, beclin 1-/- mice die as early as on embryonic day 7.5 and show excessive 
developmental defect. Moreover, neither tumorigenesis nor abnormal cell proliferation 
was observed in atg5 or atg7 (homozygous or heterozygous) deficient mice. These results 
suggest that Beclin 1 may have a more important function in embyogenesis and tumor 
suppression and this function may or may not be related to autophagy.  
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1.8 Beclin 1 and autophagy in neuronal development and diseases 
Although the pathways of autophagy are well characterized in yeast and its 
function widely studied in many tissues of mammalian animals, its exact function in the 
nervous system is not well understood. Its morphological features such as excessive 
double membrane autophagosome formation and high electron density lysosomes have 
been reported in many human neurodegenerative diseases such as transmissible 
spongiform encephalopathies, Polyglutamine diseases, Alzheimer’s disease (AD) and 
Parkinson’s disease (PD) (Williams et al., 2006; Rubinsztein et al., 2007). However it is 
still in debate whether autophagy is one of the cell death executing forces in 
neurodegenerative diseases, whether it is a failed attempt at protection, or just a 
secondary effect. Many in vivo studies in disease model mice and in vitro studies using 
cultured primary neurons have suggested that autophagy is a self protective response to 
the stress that is induced by accumulation of toxic proteins in many neurodegenerative 
diseases (Larsen and Sulzer, 2002).   
Consistent with this possible protective function, beclin 1 expression level has 
been shown to decrease in human brains in an age-dependent manner, and Beclin 1 
mediated autophagy reduces intracellular Huntingtin accumulation (Shibata et al., 2006). 
Meanwhile, Beclin 1 levels are reduced in cortical gray matter from AD patients, and 
heterozygous deletion of beclin 1 in a mouse model for AD increased the amyloid 
accumulation in neurons as well as extracellular deposit (Pickford et al., 
2008).  In addition, after closed head injury, Beclin 1 levels increases quickly and 
dramatically in both neurons and surrounding astrocytes at the injury site, suggesting that 
Beclin 1 is involved in brain response to head trauma (Diskin et al., 2005). Up-regulation 
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of Beclin 1 level and activation of autophagy are also observed in Niemann-Pick type C 
disease, one type of inherited sphingolipid storage diseases that cause neurodegeration 
and cognitive impairment (Pacheco et al., 2007). 
Induction of autophagy is also observed in non-apoptotic Purkinje cell death in 
Lurcher (Lc) mice, an extensively used model of Purkinje cell degeneration. Purkinje 
cells are specifically lost in various neurodegenerative conditions such as spinalcerebellar 
ataxia, ataxia telangectasia, autism and certain prion encephalopathies, but the molecular 
mechanism underlying Purkinje cell death is poorly understood. Lurcher is a 
spontaneous, semidominant mouse neurological mutation. A point mutation in Purkinje 
cell specific glutamate receptor changes the receptor to a constitutive active form, and 
excessive influx of calcium induces cell-autonomous death of cerebellar Purkinje cells 
(Zuo et al., 1997). Degenerating Purkinje cells exhibit elevated levels of autophagy, and 
yeast two-hybrid study using C terminal cytosolic tail of glutamate receptor as a bait 
identified Beclin 1,  suggesting that Beclin1 mediated autophagy may be related to 
Lurcher Purkinje cell degeneration (Yue et al., 2002).  
 Autophagy may be a quick response by the brain to protect itself in response to 
injury or accumulation of toxic protein aggregates. Furthermore, the basal level of 
autophagy is important in maintaining the normal function of the brain, since inhibition 
of basal autophagy in the brain has been shown to induce neurodegeneration.. When Atg5 
or Atg7 expression is specifically deleted in the central nervous system, cytosolic proteins 
in neurons accumulate, and ultimately become inclusion bodies that are ubiquitin 
positive, and activated apoptosis and neurodegeneration were observed. This suggests 
that basal level of autophagy is essential for maintaining normal functions of neurons by 
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clearing cytosolic proteins and preventing them from forming aggregates (Hara et al., 
2006; Komatsu et al., 2006).  
In addition to its critical function in mediating cell survival and cell death, 
autophagy is also important in cellular and tissue development and remodeling, through 
turnover and recycling of organelles and proteins. Unc51, which is a C. elegans ortholog 
of Atg1, is important for axonal elongation (Ogura et al., 1994), while Drosophila 
ortholog of Apg4 was identified as modifier of Notch signaling pathway, and its loss of 
function affected wing development (Thumm and Kadowaki, 2001). From its 
involvement in recycling of proteins and membranes, it can be hypothesized that 
autophagy may also be related to dynamic morphological changes of neuronal and 
synaptic structures, and that it may be involved in plasticity in the central nervous system.  
  
1.9 Summary 
As an essential protein for autophagy induction, Beclin 1 is part of the 
Vps34/PtdIns3K complex and functions at the initial step of autophagosome formation. 
Moreover, through its organelle specific binding with Bcl-2, Beclin 1 is also important in 
mediating cross talk between autophagy and apoptosis. Although it has been shown in 
yeast that Atg6p forms two distinctive complexes with different functions, and recently 
several novel Beclin 1 interaction proteins have been identified in mammalian cells, the 
exact nature of Beclin 1 complex(es) is unclear. Information regarding the function of 
Beclin 1 on neuronal development is still lacking.  Therefore in this study, we combined 
genetic and biochemical approaches to study the formation of Beclin 1 complex(es) in 
mammalian cells and the function of Beclin 1 in the central nervous system. 
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Chapter II  
Identification and Characterization of Beclin 1 Interaction Proteins 
 
2.1 Generation of beclin 1-EGFP transgenic mice 
Beclin 1-EGFP transgenic mice were generated using bacterial artificial 
chromosome (BAC) techniques. As a result of homologous recombination through BAC 
modification, EGFP-coding cDNA was inserted immediately in front of the stop codon of 
beclin 1 gene inside the BAC, and CsCl purified BAC DNA was pro-nuclear injected to 
generate transgenic mice (Fig. 1a). Positive mice that have EGFP integrated into the 
genome were identified with PCR and further confirmed with southern blot (data not 
shown). Two founder mice were obtained from injection, and both gave germ line 
transmission. Expression of Beclin 1-EGFP protein was confirmed with western blot 
using brain tissue homogenate. Using Beclin 1 antibody, it was observed that one line had 
higher expression level of Beclin 1-EGFP fusion protein than the other and the level was 
comparable to that of endogenous Beclin 1 protein (data not shown).  This line was used 
for further study. Immuno-fluorescence studies on tissue sections using anti-GFP 
antibody confirmed that Beclin 1-GFP fusion protein was localized diffusely in the 
cytoplasm, which is consistent with the reported localization of the endogenous Beclin 1 
protein (Arsov et al., 2008).  
 
2.2 Generation of beclin 1-/-; beclin 1-EGFP rescued mice 
Since beclin 1 homozygous deletion is embryonic lethal, it was tested whether Beclin 1-





Figure 1-1. Beclin 1-EGFP transgene rescued the embryonic lethality of beclin 1 
homozygous deletion (beclin 1 -/-) 
(a) Schematic representation of EGFP insertion in BAC-mediated Beclin 1-EGFP 
transgenics. 
(b) Breeding strategy for generating mice in which beclin 1-EGFP transgene replaces the 
endogenous beclin 1 alleles. Beclin 1-EGFP mice were crossed with beclin 1 +/- mice to 
generate “rescued mice” (beclin 1 -/-; beclin 1-EGFP).  
(c) Western blot analysis confirmed the replacement of endogenous Beclin 1 with Beclin 
1-EGFP in beclin 1 -/-; beclin 1-EGFP mice, as detected by anti-Beclin 1 antibody.  
(d) Theoretical distribution (Mendeline ratio) of each mouse genotype in the breeding 
experiments. In the breeding to generate rescued mice, the theoretical ratio of the rescued 
mice to the whole litter is 1/7. In this study, 11 out of a total of 69 mice (from 8 litters) 
were the beclin 1 -/-; beclin 1-EGFP genotype (chi square test with the value 0.22, p>0.6, 
df=1). In the second round breeding with the rescued mice, the theoretical ratio of the 
rescued mice born to the whole litter is 1/3, and 12 out of 36 mice (from 6 litters) were of 
that genotype. Therefore Beclin 1-EGFP completely rescued the early embryonic 
lethality in beclin 1 -/- mice, and thus can functionally substitute for the endogenous 
Beclin 1 protein. 
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lethal phenotype. Beclin 1-EGFP transgenic mice were first crossed with beclin 1 +/- mice 
to generate beclin 1+/-; beclin 1-EGFP mice, and these mice were further crossed with 
beclin 1+/- mice (Fig. 1b). Tail clips were cut and protein was extracted for western blot 
with anti-Beclin 1 antibody. Beclin 1-/-; beclin 1-EGFP mice were identified as having 
only Beclin 1-EGFP fusion protein but no endogenous Beclin 1 protein (Fig. 1c). 
Rescued mice showed a similar life span to control mice, and did not show significant 
phenotypic abnormality (data not shown). Mating was repeated and in total 69 mice were 
born from 8 mating pairs, and among them 11 mice were confirmed to be rescued mice. 
The ratio of rescued mice to total litter size was close to 1:7, which is the predicted 
number if Mandel’s law is followed (chi-square test with the value 0.22, p>0.6, df=1, Fig. 
1d). Rescued mice were further crossed with beclin 1+/- mice to test if they can reproduce 
normally. Within totally 36 mice born from 6 breeding pairs, 12 mice were rescued mice, 
and the ratio again followed the 1:3 predicted by Mandel’s law (Fig. 1d). Therefore it can 
be concluded that over-expression of Beclin 1-EGFP fusion protein completely rescued 
embryonic lethal phenotype of beclin 1 homozygous deletion, and that the Beclin 1-
EGFP fusion protein possesses the physiological function of the endogenous Beclin 1 
protein.  
 
2.3 Identification of Beclin 1 interaction proteins 
Rescued mice were used for identification of Beclin 1 interaction proteins so that 
no endogenous Beclin 1 protein would compete for binding. Whole brains, livers and 
thymuses were dissected out from rescued mice and littermate control mice, and 




Figure 1-2. Identification of novel Beclin 1-interaction proteins from beclin 1 -/-; 
beclin 1-EGFP mice 
 (a) Coomassie-stained SDS-PAGE gel revealed the Beclin 1-interacting proteins 
immuno-isolated from the brain and liver tissues of the “rescued” mice by using anti-GFP 
antibody (Lane 2 and 4). Protein bands in the gel were isolated and identified by mass 
spectrometric analysis as Vps15/p150 (band 1), Vps34/ PtdIns3K (band 3), UVRAG 
(band 4), Beclin 1-EGFP (band 5), Nrbf2 (band 7, asterisk) and two novel proteins 
Atg14L (band 6, asterisk, gi|27369860) and Rubicon (band 2, asterisk, gi|45708948). The 
control mice were the beclin 1 +/– littermates (P16) (Lane 1 and 3).  
(b) Schematic diagrams of the domain structures of Atg14L, Rubicon and Nrbf2. Atg14L 
contains two coiled-coil domains (CCD1 and CCD2), which are also homologous to 
SMC domain (Structural Maintenance of Chromosomes). Rubicon contains an N-
terminal RUN (for RPIP8, UNC-14 and NESCA) domain, a C-terminal cysteine-rich 
domain, and a CCD domain in the central of the protein sequence. Nrbf2 contains a 
coiled-coil domain in the central part of the protein. 
(c and d) HEK 293T cells were transiently transfected with either N-terminal FLAG-
tagged (d) or C-terminal EGFP-tagged (e) Atg14L, Nrbf2 and Rubicon. 
Immunoprecipitation was performed with anti-FLAG (d) or anti-GFP antibody (e).  The 
endogenous Beclin 1 co-immunoprecipitated was detected by western blot analysis using 
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antibody, proteins were separated in SDS-PAGE gel, followed by visualization with 
coomassie blue staining. Distinct bands that were only observed from rescued mice but 
not from control mice were cut out and proteins were identified with mass spectrometry. 
From rescued mouse tissues, at least seven bands were identified that were not seen from 
control tissues. In addition to Beclin 1-EGFP fusion protein itself, three were known 
Beclin 1 interaction proteins: Vps34/PtdIns3K, its activator Vps15 and UV Resistance 
Associated Gene (UVRAG). The remaining three proteins were identified as two novel 
proteins and Nuclear Receptor Binding Factor 2 (Nrbf2) (Fig. 2a). The first novel protein 
(gi|27369860) has 492 amino acids (~60 kD), has two coiled-coil domains (aa 75-95 and 
aa 148-178) and also contains homology to the conserved SMC (Structural Maintenance 
of Chromosomes) motif. The second novel protein (gi|45708948) contains 941 amino 
acids (~124 kD) and has a conserved RUN (for RPIP8, UNC-14 and NESCA) domain (aa 
49-190) near the N-terminus, a cysteine-rich domain (aa 837-890) near the C-terminus, 
and a coiled-coil domain (aa 488-508) in the central region. Since yeast Atg6p binds to 
either Atg14p or Vps38p, alignment study was performed between the two novel proteins 
and Atg14p or Vps38p. The first novel protein showed a modest 15% homology to yeast 
Atg14p, therefore was named Atg14-Like (Atg14L) (Fig. 3). The second novel protein 
showed no significant homology to either Atg14p or Vps38p, therefore was named after 
its domain structure as Rubicon for RUN domain and cysteine-rich domain containing, 













Figure 1-3. Moderate homology between Atg14L and yeast Atg14 
Protein sequences of Atg14L and yeast Atg14 were aligned to analyze possible homology 
between them. Alignment was done suing T-Coffee package (Tree based Consistency 
Objective Function For AlignmEnt Evaluation) available at server: www.tcoffee.org., 
and analysis was performed with GeneDoc application. The exact match between Atg14L 
and yeast Atg14 is 15%, and juxtaposition greater than zero is 27%. The numbers 




2.4 Confirmation of interaction with immunoprecipitation  
To confirm specific interaction between identified proteins and Beclin 1, in vitro 
reverse immunoprecipitation was performed in cultured cells. Atg14L, Rubicon and 
Nrbf2 were cloned into pEGFP-N3 vector and pCMV-FLAG2 vector, and constructs 
were transfected into human embryonic kidney (HEK) 293T cells to express C-terminal 
EGFP-tagged or N-terminal FLAG-tagged proteins. Cell lysates were collected and 
immunoprecipitations were performed using either anti-GFP or anti-FLAG antibody. 
Both antibodies pulled down endogenous Beclin 1 as well as tagged proteins (Fig. 2c and 
2d). Therefore the interaction between Beclin 1 and the three identified proteins is indeed 
real and specific, and is not dependent on protein tags. Among these three identified 
proteins, Atg14L and Rubicon pulled down much more Beclin 1 than Nrbf2, suggesting 
that Atg14L and Rubicon interact with Beclin 1 much more strongly than Nrbf2. 
Therefore, we decided to focus our study on Atg14L and Rubicon first. 
 
2.5 Mapping binding domains 
Beclin 1 has three domains: Bcl-2-binding domain (BD), coiled-coil domain 
(CCD) and evolutionary conserved domain (ECD). Bcl-2 binding domain, as the name 
indicates, is essential for interaction between Beclin 1 and Bcl-2 (Pattingre et al., 2005). 
The evolutionary conserved domain is important for interaction between Beclin 1 and 
Vps34/PtdIns3K, while the coiled-coil domain was shown to be mediating direct binding 
between Beclin 1 and UVRAG (Furuya et al., 2005; Liang et al., 2006). In order to 
determine which domains within Beclin 1 are mediating its interaction with Atg14L and 






Figure 1-4. Mapping of the binding domains within Beclin 1 that mediate its 
interaction with Atg14L and Rubicon 
(a) Schematic representations of Beclin 1 domain structures and the construction of 
multiple deletion mutants. All Beclin 1 mutants were tagged with FLAG at N-termini.  
(b and c) Domains within Beclin 1 that mediate its binding with Atg14L or Rubicon. 
HEK293T cells were co-transfected with FLAG-tagged Beclin 1 mutant constructs and 
GFP-tagged full-length Atg14L (c) or Rubicon (d). The immunoprecipitation was 
performed with anti-GFP antibody, followed by Western blot with anti-FLAG antibody. 
The results of these experiments are summarized in a table under panel c and d.   “+” or 
“-” indicated positive or negative interactions between the tested protein domains. These 
experiments showed that coiled-coil domain of Beclin 1 alone (FlAG-CCD) is sufficient 
for binding with Atg14L but with evolutionarily conserved domain added (FLAG-CE) 
the binding became much stronger; only FLAG-CE of Beclin 1, not other Beclin 1 
mutants, bound to Rubicon. Abbreviations: B – Bcl2 binding domain, C – Coiled-coil 
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combinations were cloned into pCMV-FLAG2 vector to generate a series of deletion 
mutants (Fig. 4a). These mutation constructs were co-transfected into HEK 293T cells 
with either Atg14L-EGFP or Rubicon-EGFP, and immunoprecipitation was performed 
using anti-GFP antibody, followed by western blot using anti-FLAG antibody. As a result, 
Atg14L-EGFP pulled down FLAG-CCD, FLAG-BC (BD and CCD) and FLAG-CE 
(CCD and ECD), suggesting that CCD of Beclin 1 alone is sufficient for its interaction 
with Atg14L. Interestingly, the amount of immunoprecipitated FLAG-CE was 
significantly higher than that of FLAG-CCD, while the amount of immunoprecipitated 
FLAG-BC was comparable to that of FLAG-CCD, suggesting that ECD of Beclin 1 is 
not essential for but greatly enhances its interaction with Atg14L (Fig. 4b). Meanwhile, 
Rubicon-EGFP pulled down only FLAG-CE, but not any other deletion mutant of Beclin 
1, suggesting that CCD and ECD of Beclin 1 are both required for its interaction with 
Rubicon (Fig. 4c).  
A similar strategy was used to determine the domains within Atg14L and Rubicon 
that mediate their binding to Beclin 1. A series of deletion mutants of Atg14L and 
Rubicon were generated and transfected into HEK293T cells to test their ability to pull 
down endogenous Beclin 1 and Vps34/PtdIns3K proteins (Fig. 5a). Atg14L-EGFP with 
the first coiled-coil domain deleted pulled down smaller amount of endogenous Beclin 1 
than full length Atg14L-EGFP, and when both coiled-coil domains were deleted, no 
endogenous Beclin 1 was detectable from immunoprecipitation. This result suggested 
that both coiled-coil domains within Atg14L are important for it to maintain sufficient 
interaction with Beclin 1.  Likewise,  Atg14L  without coiled-coil domains was not able 





Figure 1-5. Mapping domains within Atg14L and Rubicon that are required for 
their interaction with Beclin 1 
(a) Schematic representations of Atg14L and Rubicon domain structures and the 
construction of multiple deletion mutants. All Atg14L and Rubicon mutants were tagged 
with EGFP at C-termini.  
 (b and c) Domains within Atg14L or Rubicon that are required for their binding with 
Beclin 1. HEK293T cells were transfected with EGFP-tagged Atg14L (b) or Rubicon (c) 
mutant constructs. The immunoprecipitation was performed with anti-GFP antibody, 
followed by Western blot analyses of endogenous Beclin 1 and Vps34/PtdIns3K with 
anti-Beclin 1 and Vps34/PtdIns3K antibodies. The results of these experiments are 
summarized in a table at bottom of panel b and c. “+” or “-” indicated positive or 
negative interactions between the tested protein domains. These experiments showed that 
both CCD1 and CCD2 of Atg14L are important for its binding to Beclin 1. Meanwhile, 
neither RUN nor Cys-rich domain of Rubicon is required for its binding to Beclin 1. Thus, 
central region containing CCD is important for the binding. In addition, Rubicon mutants 
lacking RUN, Cys-rich domain or both domains have increased binding to Beclin1. 
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Interestingly, when either RUN domain or cysteine-rich domain was deleted from 
Rubicon-EGFP, larger amount of endogenous Beclin 1 was immunoprecipitated, and 
Rubicon-EGFP with both domains simultaneously deleted pulled down the largest 
amount of Beclin 1. It is therefore suggested that RUN domain and cysteine-rich domain 
are not only unnecessary but also somehow inhibitory for the interaction between 
Rubicon and Beclin 1, and that the interaction with Beclin 1 is probably mediated by the 
coiled-coil domain in the central region of Rubicon. The same pattern was observed for 
interaction between Rubicon and Vps34//PtdIns3K (Fig. 5c). 
 
2.6 Identification of Beclin 1-containing protein complexes 
In yeast, Atg6p/Vps30p forms two distinctive protein complexes. One contains 
Atg14p and is essential for autophagy induction, and the other contains Vps38p and 
functions in vacuolar protein carboxypeptidase Y (CPY) sorting pathway (Kihara et al., 
2001b). However in mammalian cells it is still unknown whether there are multiple 
Beclin 1 complexes and what are the components of the complex(es). The in vivo 
immunoprecipitation in this study identified at least six Beclin 1 interaction proteins, and 
it is an interesting question how many protein complexes these proteins can form. To 
answer this question, immunoprecipitation was first performed in NIH/3T3 mouse 
fibroblast cells using anti-Atg14L and anti-Rubicon antibodies. As a result, anti-Atg14L 
antibody pulled down Beclin 1 and Vps34/PtdIns3K, but not Rubicon or UVRAG, while 
anti-Rubicon antibody pulled down Beclin 1 and Vps34/PtdIns3K as well as UVRAG, 
but not Atg14L (Fig. 6a). This suggested that like yeast there may also be distinctive 







Figure 1-6. Analysis of protein interactions among endogenous proteins in NIH/3T3 
cells and HEK293 cells stably expressing Atg14L-EGFP or Rubicon-EGFP 
(a) Immunoprecipitation of endogenous proteins that interact with Atg14L and Rubicon 
using anti-Atg14L and anti-Rubicon antibodies from NIH/3T3 cell lysate. The control 
experiments were preformed using the corresponding pre-immune serum for each 
antibody. The whole cell lysate (WCL) and immunoprecipitated samples (IP) were 
examined by western blot using antibodies against UVRAG, Vps34/PtdIns3K, Atg14L 
and Rubicon. 
(b) Immunoprecipitation of endogenous proteins that interact with Atg14L and Rubicon 
using anti-GFP antibodies from HEK293 cells stably expressing Atg14L-EGFP or 
Rubicon-EGFP. The whole cell lysate (WCL) and immunoprecipitated samples (IP) were 
examined by western blot with antibodies against UVRAG, GFP, Vps34//PtdIns3K and 
Beclin 1. Atg14L-EGFP co-immunoprecipitated with Vps34 and Beclin 1; Rubicon-













































































exist in separate Beclin 1-containing protein complexes, and that UVRAG may be in the 
same complex with Rubicon but not with Atg14L. Consistent with this idea, 
immunoprecipitation with anti-GFP antibody performed in HEK293 cells stably 
expressing either Atg14L-EGFP or Rubicon-EGFP showed that only Rubicon-EGFP 
pulled down UVRAG although they both pulled down endogenous Beclin 1 and 
Vps34/PtdIns3K (Fig. 6b). 
To further characterize the composition of possible Beclin 1 protein complexes in 
vivo, size exclusion chromatography (gel filtration) was performed. In this technique 
protein complexes are separated according to their sizes (uisng mild condition). Wild-
type or “rescued” mouse livers were homogenized and soluble cytosolic protein extract 
was prepared with centrifugation, after which the extract was run through a column. 
Eighty fractions were collected and analyzed by western blot using anti-Atg14L, anti-
Rubicon, anti-Vps34/PtdIns3K, anti-Beclin 1 and anti-UVRAG antibodies. From both 
wild-type and “rescued” mice, Vps34/PtdIns3K and Beclin 1 proteins were detected in 
similar fractions and their levels peaked in the same fractions of 39-40 (Beclin 1-GFP in 
“rescued” mice). Interestingly, Atg14L and Rubicon levels also showed similar 
distribution among all fractions and the strongest signals in the similar fractions (Figs. 7a 
& 7b), suggesting that these fractions contain a major Beclin 1-Vps34/PtdIns3K complex 
that may include both Atg14L and Rubicon proteins. From protein size markers, it was 









Figure 1-7. Analysis of protein composition in the Beclin 1 complex(es) 
(a) Western blot analyses of Beclin 1, Vps34, Atg14L and Rubicon in the gel filtration 
fractions from wild type mouse liver extract. The peak levels of each protein were found 
co-eluded in the same fractions (39-40). Atg14L was also found eluted at the second peak 
levels in later fractions (53-54). The cell lysate of FLAG-Atg14L-transfected HEK 293T 
was loaded as a positive control (labeled with “1”) for the migration position of the 
Atg14L protein. The adjacent lane (labeled with “2) was loaded with cell lysates without 
transfection.  
(b) Western blot analyses of Beclin 1, Vps34, Atg14L and Rubicon in the gel filtration 
fractions from the “rescued” mice liver samples. The liver lysate was prepared from 
“rescued” mice beclin 1 –/–; beclin 1-GFP and applied in gel filtration experiment. 
Western blot analyses of Beclin 1, Vps34, Atg14L and Rubicon in the gel filtration 
fractions is shown. The peak levels of each protein were found co-eluded in the same 
fractions (~41-43). Atg14L was also found eluted at the second peak levels in later 


















































To validate the protein detection by anti-Atg14L or anti-Rubicon antibodies in the 
above study, the same experiment was repeated using cell lysate from HEK293 cells 
stably expressing either Atg14L-EGFP or Rubicon-EGFP, followed by western blot 
analyses with anti-GFP and anti-Beclin 1 antibodies (Fig. 8). The results from the 
Atg14L-EGFP stable cell lysate again showed that the fractions containing peak levels of 
Beclin 1 overlapped with that of Atg14L-EGFP (both peak fractions eluted at 39-40; Fig. 
8), confirming the results using anti-Atg14L antibody for detecting endogenous proteins 
in the liver (Fig. 7). Interestingly, the samples prepared from starved Atg14L-EGFP 
stable cells showed no difference in the distribution pattern for Atg14L or Beclin 1 as 
compared to that from non-starved cells (Fig. 8), suggesting that starvation does not 
increase or decrease the binding between Atg14L and Beclin 1. Similar studies using 
lysate from Rubicon-EGFP stable cells also confirmed the results using anti-Rubicon 
antibodies for detecting endogenous Rubicon protein in mouse liver, and starvation did 
not change the interaction between Rubicon and Beclin 1 (Fig. 8).  
Western blot was also performed on liver and cell lysate fractions with UVRAG 
antibody. However, no clear signal was detected. The possible reason may be the quality 
of the anti-UVRAG antibody used, or that the binding of UVRAG in the whole protein 
complex is not stable or strong enough to endure the experimental procedures of gel 
filtration, and therefore UVRAG may have eluted as single molecules in late fractions 
that were not collected.  
In conclusion, gel filtration experiments showed that there is one major in vivo 
Beclin 1-containing protein complex that contains both Atg14L and Rubicon, and that 







Figure 1-8. Gel filtration analyses of protein distribution using stably transfected 
cells  
(a) Western blot analyses of Atg14L-EGFP and Beclin 1 in the gel filtration fractions of 
non-starved (left panel) and starved (for 2h, right panel) using Atg14L-EGFP HEK293 
stable cell lysate. Atg14L-EGFP (recognized by anti-GFP antibody as a ca. 85 kDa band) 
and Beclin 1 co-eluted in fractions around 39-40, supporting the specificity of the anti-
Atg14L antibody (Fig. 7a&b). No change in the elution pattern was detected after the 
cells were starved for 2h. 
(b) Western blot analyses of Rubicon-EGFP and Beclin 1 in the gel filtration fractions of 
non-starved (left panel) and starved (for 2h, right panel) using Rubicon-EGFP HEK293 
stable cell lysate. Rubicon-EGFP and Beclin 1 co-eluted in many fractions, supporting 
the specificity of the anti-Rubicon antibody (Fig. 7a&b). No change in the elution pattern 
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In order to confirm the results from gel filtration that Atg14L and Rubicon are 
able to co-exist in the same protein complex, tagged proteins were expressed in cultured 
HEK293T cells and co-immunoprecipitation with anti-GFP antibody was performed. As 
a result, Atg14L-EGFP was able to pull down FLAG-Rubicon (Fig. 9a), and Rubicon-
EGFP pulled down FLAG-Atg14L as well (Fig. 9b). In both cases, Atg14L-EGFP and 
Rubicon-EGFP were able to pull down endogenous Beclin 1, indicating that Beclin 1 was 
also in the protein complex. Since gel filtration results did not indicate binding of 
UVRAG in the protein complex, co-immunoprecipitation was performed in HEK293T 
cells to study the binding between UVRAG-EGFP and FLAG-Atg14L or FLAG-Rubicon. 
With anti-GFP antibody, UVRAG-EGFP pulled down both FLAG-Atg14L and FLAG-
Rubicon, as well as endogenous Beclin 1 and Vps34/PtdIns3K, indicating that UVRAG 
can also be in the same protein complex (Fig. 9c).  
 
2.8 Binding inter-relations 
When multiple proteins form a protein complex, they may affect the binding 
affinity of each other in either positive way, in which case a certain protein may increase 
the binding between other proteins, or in negative way, in which case a certain protein 
may inhibit the binding between other proteins. In order to study whether such 
interactions exist among the proteins of Beclin 1-Vps34/PtdIns3K complex, co-








Figure 1-9. Protein interactions among Beclin 1, ATG14L, Rubicon and UVRAG 
assayed in transiently transfected cells 
(a-b) Co-immunoprecipitation experiments showing protein-protein interaction between 
Atg14L and Rubicon. HEK293T cells were co-transfected with EGFP-tagged Atg14L 
and FLAG-tagged Rubicon (a), or EGFP-tagged Rubicon and FLAG-tagged Atg14L (b). 
Cell lysate was used for immunoprecipitation with anti-GFP antibody, followed by 
western blot with anti-FLAG antibody. EGFP-tagged Atg14L was able to pull down 
FLAG-tagged Rubicon (a), and vice versa (b). WCL: whole cell lysate; IP: 
immunoprecipirated. 
(c) Protein interaction between co-expressed UVRAG and Atg14L/Rubicon. HEK293T 
cells were co-transfected with UVRAG-EGFP and FLAG-Atg14L or FLAG-Rubicon. 
Immunoprecipitation was performed with anti-GFP antibody, followed by detection with 
anti-FLAG antibody. The result shows that both FLAG-Atg14L and FLAG-Rubicon was 




































































































































2.8.1 Atg14L increases, and Rubicon reduces, interaction between Beclin 1 and 
Vps34/PtdIns3K 
Previous study showed that in mammalian cells, almost all Beclin 1 protein forms 
complexes with Vps34/PtdIns3K while not all Vps34/PtdIns3K is interacting with Beclin 
1 (Kihara et al., 2001a). In order to study if the presence of Atg14L or Rubicon affects 
the interaction between Beclin 1 and Vps34/PtdIns3K, two sets of co-transfection 
experiments were performed. In the first set, Beclin 1-EGFP was co-transfected into 
HEK293T cells with empty pCMV-FLAG vector, FLAG-tagged Atg14L or FLAG-
tagged Rubicon, followed by immunoprecipitation using anti-GFP antibody. The level of 
endogenous Vps34/PtdIns3K protein that was immunoprecipitated with the anti-GFP 
antibody was detected with western blot and compared. In the second set, Myc-tagged 
Vps34/PtdIns3K was co-transfected into HEK293T cells with empty pCMV-FLAG 
vector, FLAG-tagged Atg14L or FLAG-tagged Rubicon, followed by 
immunoprecipitation using anti-Myc antibody. And the level of endogenous Beclin 1 
protein that was immunoprecipitated was detected and compared. In the first set, 
compared to empty vector control, FLAG-Rubicon significantly reduced the level of 
Vps34/PtdIns3K that was pulled down with Beclin 1-EGFP while FLAG-Atg14L did not 
show significant effect (Fig. 10a). Meanwhile in the second set, when empty vector was 
co-transfected Myc-Vps34/PtdIns3K was only able to pull down extremely small amount 
of endogenous Beclin 1, probably due to the low efficiency of immunoprecipitation with 
anti-Myc antibody. However when FLAG-Atg14L was co-transfected, an increased 
amount of endogenous Beclin 1 was pulled down. And with co-transfection of FLAG-
Rubicon,  the  amount  of  Beclin 1  pulled  down  was too  small  to  assess  the effect of  
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Figure 1-10. Binding inter-relationship among Beclin 1 interaction proteins 
(a) Co-immunoprecipitation of endogenous Vps34/PtdIns3K with Beclin 1-EGFP in the 
presence of over-expressed FLAG-Atg14L or FLAG-Rubicon. Beclin 1-EGFP was co-
expressed with FLAG-Atg14L, FLAG-Rubicon or control FLAG vector in HEK 293T 
cells. Immunoprecipitation was performed with anti-GFP antibody, followed by western 
blot with anti-Vps34 antibody to detect endogenous Vps34/PtdIns3K. Notably, over-
expression of FLAG-Rubicon, but not FLAG-Atg14L, repressed the amount of 
endogenous Vps34/PtdIns3K that interacted with Beclin 1-EGFP. 
(b) Co-immunoprecipitation of endogenous Beclin 1 with Myc-Vps34/PtdIns3K in the 
presence of over-expressed FLAG-Atg14L or FLAG-Rubicon. Immunoprecipitation was 
performed with anti-Myc antibody, followed by Western blot with anti-Beclin 1 antibody 
to detect Endogenous Beclin 1. Over-expression of FLAG-Atg14L increased the amount 
of endogenous Beclin 1 that interacted with Myc-Vps34/PtdIns3K. 
(c) Co-immunoprecipitation of Beclin 1 and Vps34/PtdIns3K with Atg14L-EGFP or 
Rubicon-EGFP. Atg14L-EGFP or Rubicon-EGFP was co-expressed with Myc-
Vps34/PtdIns3K, either with or without Beclin 1-AsRed in HEK293T cells. 
Immunoprecipitation was performed using anti-GFP antibody followed by blotting with 
anti-Vps34/PtdIns3K and anti-Beclin 1 antibodies. Over-expression of Beclin 1-AsRed 
increased the binding between Atg14L-EGFP and Myc-Vps34/PtdIns3K 
(d-e) Effect of Beclin 1 over-expression on protein interaction between co-expressed 
UVRAG and Atg14L/Rubicon. UVRAG-EGFP was co-expressed with either FLAG-
Atg14L or FLAG-Rubicon in HEK 293T cells, in the absence or in the presence of Beclin 
1-Myc. Immunoprecipitation was performed with anti-GFP antibody, followed by 
detection with anti-FLAG and anti-Myc antibodies. The results show that Beclin 1 over-
expression markedly increased the amount of FLAG-Rubicon that was co-
immunoprecipitated with UVRAG-EGFP (e) while having little effect on interaction 
between FLAG-Atg14L and UVRAG-EGFP (d).  
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Rubicon (Fig. 10b). The results from these two sets of co-immunoprecipitation 
experiments suggested that Atg14L increased while Rubicon reduced the interaction 
between Beclin 1 and Vps34/PtdIns3K. 
 
2.8.2  Effect of Beclin 1 on interaction between Atg14L/Rubicon and Vps34/PtdIns3K 
As a component of the Vps34/PtdIns3K complex, Beclin 1 may as well affect 
binding of other protein components to the Vps34/PtdIns3K. Therefore co-transfection 
and immunoprecipitation experiments were performed to test the effect of Beclin 1 on 
interaction between Atg14L or Rubicon and Vps34/PtdIns3K. For this purpose, triple 
transfection was performed using Atg14L-EGFP/Rubicon-EGFP, Myc-Vps34/PtdIns3K 
and either empty pAsRed2-N1 vector or Beclin 1-AsRed. Immuno-precipitation was 
performed with anti-GFP antibody, and the level of Myc-Vps34/PtdIns3K that was pulled 
down was detected with Vps34 antibody and compared between the conditions of empty 
vector co-trasfection and Beclin 1-AsRed co-transfection. As a result, the presence of 
Beclin 1-AsRed greatly increased the amount of Myc-Vps34/PtdIns3K that was pulled 
down with Atg14L-EGFP yet had no significant effect on that pulled down with 
Rubicon-EGFP. This suggested that Beclin 1 increased the interaction between Atg14L 
and Vps34/PtdIns3K but did not affect the interaction between Rubicon and 
Vps34/PtdIns3K.  
Taken together, the co-immunoprecipitation experiments showed that Beclin 1 
and Atg14L increase each other’s interaction with Vps34/PtdIns3K, and that Rubicon 
inhibits the interaction between Beclin 1 and Vps34/PtdIns3K. 
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2.8.3  Effect of Beclin 1 on interaction between Atg14L/Rubicon and UVRAG 
Immunoprecipitation with Atg14L or Rubicon antibodies from NIH/3T3 cells or 
with GFP antibody from HEK293 cells stably expressing Atg14L-EGFP or Rubicon-
EGFP showed that Rubicon has strong interaction with UVRAG but Atg14L does not 
(Fig. 6a and 6b). Meanwhile, immunoprecipitation from transiently transfected cells 
showed that UVRAG could be in the same complex with both Atg14L and Rubicon. In 
order to study how their interaction is related to Beclin 1, triple transfection was 
performed in which UVRAG-EGFP, FLAG-Atg14L or FLAG-Rubicon, and either 
control empty vector or Beclin 1-Myc were co-transfected into HEK293T cells. 
Immunoprecipitation was performed with anti-GFP antibody, followed by western blot 
with anti-FLAG and anti-Myc antibodies. The results showed that the amount of FLAG-
Rubicon that immunoprecipitated with UVRAG-EGFP increased dramatically when 
Beclin 1 was co-transfected, indicating that Beclin1 significantly increased binding 
between UVRAG and Rubicon (Fig. 10e). However Beclin 1 co-transfection had no 
effect on the interaction between UVRAG-EGFP and FLAG-Atg14L (Fig. 10d).  
 
2.9 Functional assays of Atg14L  
2.9.1  Atg14L positively regulates autophagy 
Beclin 1 forms a protein complex with Vps34/PtdIns3K and regulates the level of 
autophagy in mammalian cells. In order to study the function of the novel protein Atg14L, 
its effect on autophagy levels was first studied. RNA interference (RNAi) was used to 
suppress the expression of endogenous Atg14L gene and knock down the protein level of 
Atg14L in NIH/3T3 cells. First, LC3 protein levels from the cell lysate were examined 
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after siRNA transfection. LC3 is the mammalian ortholog of Atg8, and undergoes 
modification from LC3 I form that is localized in the cytosol to LC3 II form that is bound 
to the autophagosome membrane. Anti-LC3 antibody detects both forms, and the ratio 
between the cytosolic I form and the membrane bound II form is correlated with the 
number of autophagosome and therefore the autophagy level in the cells. Compared to 
control siRNA, Atg14L siRNA transfection greatly increased the LC3 II form level, 
indicating that autophagy level was changed (Fig. 11a). However, the increase in LC3 II 
form level can be either from an increase of autophagosome formation, which means an 
increase of autophagy level, or from a decrease of lysosomal degradation of 
autophagosomes, which means a decrease of autophagy level. Interestingly, transfection 
of Beclin 1 siRNA also induced a significant increase of LC3 II level that is comparable 
to that induced by Atg14L siRNA transfection. Beclin 1 functions in autophagy induction 
and deletion of Beclin 1 inhibits autophagy. The similar changes in LC3 II form levels 
that Atg14L siRNA and Beclin 1 siRNA induced suggested that Atg14L is related to 
autophagy regulation and that it may function in the same direction as Beclin 1. To 
confirm the function of Atg14L on autophagy regulation, the level of another autophagy 
related protein, p62/SQSTM1 was examined. P62/SQSTM1 was identified as a LC3 
interaction protein and is degraded by autophagy (Komatsu et al., 2007b; Pankiv et al., 
2007). Therefore the p62/SQSTM1 protein level can be used as a more reliable marker 
for autophagy level. Western blot with anti-p62/SQSTM1 antibody showed that 
transfection of both Atg14L and Beclin 1 siRNA significantly increased the 
p62/SQSTM1 protein level compared to control siRNA. This result confirmed that like 





Figure 1-11. Atg14L functions in positive regulation of autophagy 
(a) Beclin 1 or Atg14L RNAi knock-down in the NIH/3T3 cells led to increased levels of 
p62/SQSTM1 and LC3 II form as detected with anti-p62/SQSTM1 and LC3 antibodies 
under both normal (left panel) and nutrient-starvation conditions (right panel). Notably, 
Beclin 1 RNAi knock-down markedly reduced levels of Atg14L expression. -actin was 
blotted as the loading control.  
(b) Confocal images of MLE12 cells stably expressing GFP-LC3 showed that Atg14L 
RNAi knock-down resulted in markedly increased number of large size GFP-LC3 puncta, 
as compared to the control RNAi treatment. Scale bar, 10 m. 
(c-d) Confocal images of MLE12 cells stably expressing GFP-LC3 showed that Atg14L-
RNAi-induced large-size GFP-LC3 puncta (in green) colocalized with p62/SQSTM1 (c, 
in red) and ubiquitin (d, in red). Scale bar, 10 m. 
 (e) Atg14L siRNA, as compared to control siRNA, decreased long-lived protein 
degradation in NIH/3T3 cells under both normal (p=0.007) and starvation (p=5E-6) 
conditions (asterisks, one-tailed Student’s t-test with equal variances, n = 4). This 
difference was diminished when the starved cells were treated with 3-methyladenine 
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thereby indicating that like Beclin 1, knockdown of Atg14L impaired autophagy level in 
the cells. When cells were deprived of serum and amino acids to induce autophagy, 
transfection of Beclin 1 or Atg14L siRNA resulted in the same accumulation of 
p62/SQSTM1 and both LC3 I and II forms, indicating that autophagy was inhibited as 
well under starvation conditions (Fig. 11b).  Interestingly, Beclin 1 siRNA transfection 
also resulted in a significant decrease of Atg14L protein level, suggesting that Beclin 1 
may be essential for stabilization of Atg14L. 
In a parallel experiment, Atg14L protein levels were knocked down in MLE12 
cells that stably expressed the autophagy reporter, GFP-LC3 fusion protein. Compared to 
control siRNA, Atg14L siRNA transfection resulted in accumulation of many large-sized 
punctate structures that were positive for GFP-LC3 (Fig. 11c). These structures were 
stained positively with anti-p62/SQSTM1 and anti-ubiquitin antibodies, indicating that 
they are accumulation of ubiquitinated proteins they failed to be degraded by lysosomes 
because of down-regulation of autophagy (Fig. 11d). 
To further confirm the positive regulation of autophagy by Atg14L, long-lived 
protein degradation rate was measured and compared in control or Atg14L siRNA 
trasnfected NIH/3T3 cells. Unlike short-lived proteins that are degraded by ubiquitin-
proteasome system, long-lived proteins are degraded by autophagy and therefore the rate 
of degradation can be used as an indicator of the level of autophagy. When the long-lived 
protein degradation rate in control siRNA transfected cells under normal culture 
conditions was set as 1.00 fold as normalization standard, Atg14L siRNA transfection 
reduced the degradation to 0.90 fold, which is a small yet significant difference (p<0.001). 
Upon starvation, autophagy in cells was induced and the long-lived protein degradation 
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rate in control RNAi transfected cells increased to 2.73 folds, and again Atg14L siRNA 
transfection reduced it to 1.71 folds (~37%, p=5E-6). Finally when cells were put under 
starvation conditions and treated with a specific autophagy inhibitor 3-methyladenie (3-
MA), long-lived protein degradation rates in control siRNA and Atg14L siRNA 
transfected cell were reduced to 0.83 fold and 0.77 fold respectively, and no significant 
difference was observed between the two conditions (Fig. 11e). These results indicated 
that knockdown of Atg14L protein level indeed inhibited autophagy, therefore Atg14L 
positively regulates autophagy.  
 
2.9.2  Atg14L positively regulates Vps34/PtdIns3K lipid kinase activity 
Vps34/PtdIns3K is essential for autophagy induction, and it is a type III 
phosphoinositide 3 (PI 3)-kinase that generates phosphotidylinositol 3-phosphate 
(PtdIns(3)P) from the substrate phosphatidylinositol (PI). Recently identified Beclin 1 
interaction proteins UVRAG and Bif-1 both positively regulate Vps34/PtdIns3K kinase 
activity and autophagy. To study whether Atg14L may also function on Vps34/PtdIns3K, 
a kinase activity assay was performed. A plasmid that contains both Myc-tagged 
Vps34/PtdIns3K and its co-activator Vps15 was used, since the co-expression of Vps15 
was reported to enhance Vps34/PtdIns3K kinase activity and therefore increase the 
sensitivity of the assay (Yan et al., 2008). Myc-Vps34/PtdIns3K-Vps15 was co-
transfected with either empty pCMV-FLAG vector or FLAG-Atg14L, and IP was 
performed using Myc antibody. Immunoprecipitated Myc-Vps34/PtdIns3K was 
subsequently used for in vitro kinase activity assay, and generated PtdIns(3)P was 







Figure 1-12. Atg14L positively regulates Vps34/ PtdIns3K kinase activity 
(a) HEK 293T cells were co-transfected with myc-Vps34/PtdIns3K-Vps15 and FLAG-
Atg14L or FLAG vector, either in the absence or in the presence of Beclin 1-EGFP. Myc-
Vps34-Vps15 was immunoprecipitated with anti-Myc antibody for the in vitro kinase 
activity assay. The resulting radioactive PtdIns(3)P was separated by thin layer 
chromatography (TLC) (lower panel), quantified and normalized against the amount of 
immunoprecipitated myc-tagged Vps34/PtdIns3K as measured by Western blot (upper 
panel).  
(b) The quantified results showed that over-expressing Atg14L significantly up-regulated 
the Vps34 kinase activity by 2.5 folds with simultaneous over-expression of Beclin 1 
(asterisk, p=0.04, one-tailed Student’s t-test with unequal variances, n=5). Without over-
















































When only two plasmids were co-transfected, FLAG-Atg14L did not change the 
Vps34/PtdIns3K kinase activity compared to empty control vector. However, when 
Beclin 1-EGFP was co-transfected with FLAG-Atg14L, there was a significant 2.5 folds 
change in Vps34/PtdIns3K kinase activity compared to control vector (Fig. 12b). 
Therefore, Atg14L positively regulates Vps34/PtdIns3K kinase activity, and Beclin 1 is 
essential for this regulatory function.  
 
2.9.3  Beclin 1 and Atg14L synergistically promote autophagosome biogenesis  
Although it has been shown that Beclin 1 is localized on trans-Golgi network 
(TGN) and near mitochondria, the majority of it is diffusely localized throughout the 
cytosol, and half of the protein is within soluble portion of the cells (Kihara et al., 2001a; 
Pattingre et al., 2005). Staining of tissue sections from Beclin 1-EGFP mice also showed 
diffuse intracellular localization of Beclin 1-EGFP in cells (Arsov et al., 2008). The 
intracellular localization of Beclin 1-EGFP after transient transfection or in Beclin 1-
EGFP HEK293 stable cells was consistent with these previous reports (Fig. 13a). 
Meanwhile, Atg14L-EGFP mainly showed diffuse intacellular localization in HEK293 
cells stably expressing Atg14L-EGFP (Fig. 13a). In order to study the inter-relation 
between localization of Beclin 1 and Atg14L, Beclin 1-AsRed and Atg14L-EGFP were 
co-transfected into Hela cells. Upon co-transfection, both proteins showed dramatic 
changes in intracellular localization and both became localized on numerous punctate 
structures. On these punctate structures, Beclin 1-AsRed and Atg14L-EGFP showed 
complete co-localization (Fig. 13b). In order to reveal the identity of the punctate 
structures,  electron  microscopy  (EM)  studies  were  performed  on  HEK293T  cells  
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Figure 1-13.  Synergistic effects of Beclin 1 and Atg14L in promoting double 
membrane formation 
(a) Beclin 1-EGFP and Atg14L-EGFP are diffuse in cytoplasm of HEK-293 cells stably 
transfected with Beclin 1-EGFP or Atg14L-EGFP plasmids. Scale bar: 10 m.  
(b) Co-expression and co-localization of Atg14L-EGFP (green) & Beclin 1-AsRed (red) 
on punctate structures in co-transfected HeLa cells, with Pearson’s coefficient (PC) 0.91. 
Scale bar: 10 m. 
(c) Electron microscopic images showed that co-transfection with Atg14L-EGFP and 
Beclin 1-AsRed caused the formation of large size organelles (red asterisks) that were 
often enwrapped with double membranes in HEK 293T cells:  (c1) concentric membrane 
“rings”; (c2) two large structures (3-5 m in diameter) containing materials with high 
electron density. The inset shows high magnification of enwrapping double membranes; 
(c3) formation of many autophagosomes (yellow arrows) in cytoplasm; (c4) Immuno-
electron microscopic image showing a structure enwrapped with concentric membrane 
“rings” labeled with anti-GFP antibody. Abbreviations: M – mitochondria, N – nucleus. 
Scale bar: 500 nm. 
(d) Co-localization of Beclin 1-myc (blue), Atg14L-AsRed (red) and GFP-LC3 (green). 
HeLa cells stably expressing GFP-LC3 were transiently transfected with Beclin 1-myc 
and Atg14L-AsRed and stained with anti-Myc antibody. Scale bar: 10 m.  
 (e-f) Atg12-EGFP and Atg5-EGFP (green) were colocalized with the puncta associated 
with the Atg14L-AsRed (red) and Beclin 1-Myc (blue) (arrows) in transfected HeLa cells. 
Some of these puncta (yellow arrows) appeared to be “ring” shape (see the inset).  Scale 



























co-transfected with Beclin 1-AsRed and Atg14L-EGFP. Under EM, numbers of electron 
dense structures that have large-size (~3-5 micron in diameter) were observed, and such 
structures were virtually absent in single plasmid or control empty vector transfected cells 
(data not shown). Some of these structures displayed concentric “rings” with double 
membranes (Fig. 13c1), and many were large vacuoles filled with materials of high 
electron density (Fig. 13c2). Interestingly, these large organelles were enwrapped with 
double-membranes (e.g., Fig. 13c2 inset), which are distinguished from typical 
aggresomes or protein aggregates that are usually not associated with limiting membranes. 
Meanwhile, increased numbers of double membrane autophagosomes were also observed 
in the cells overexpressing Atg14L-EGFP and Beclin 1-AsRed (Fig. 13c3).  In addition, 
as shown by immuno-EM using anti-GFP antibody, these large organelles were mostly 
positive for Atg14L-EGFP (Fig. 13c4), indicating that they are the punctate structures on 
which Beclin 1-AsRed and Atg14L-EGFP co-localized under fluorescence microscopy 
(Fig. 13b).   
Like Atg6 in yeast, Beclin 1 functions with Vps34/PtdIns3K at the nucleation step 
of autophagosome formation. They are localized on pre-autophagosomal structure (PAS), 
and are also essential for localization of other autophagy protein to PAS (Kihara et al., 
2001b; Suzuki et al., 2001). To further study the relationship of Beclin 1-Atg14L-labeled 
structures to other autophagy proteins, Beclin 1-Myc and Atg14L-AsRed were co-
transfected into HeLa cells stably expressing GFP-LC3. Again, co-expression of Beclin 
1-Myc (blue) and Atg14L-AsRed (red) causes formation of Beclin 1-BISC punctate 
structures, and GFP-LC3 was also localized on these structures (green) (Fig. 13d), 
suggesting that the Beclin 1-Atg14L structures likely recruit LC3. Moreover, when 
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transfection of Atg14L-AsRed, Beclin 1-Myc and EGFP-Atg12 (or EGFP-Atg5) was 
performed in HeLa cells, EGFP-Atg12 or EGFP-Atg5 (green) was also co-localized on 
the Atg14L-Beclin 1 punctate structures (red and blue, respectivley) (Fig. 13e&f), 
suggesting that these Beclin 1-Atg14L structures may also recruit Atg12 and Atg5, whose 
conjugation is required for autophagosome expansion and association of LC3 to 
autophagosome membranes (Mizushima et al., 2001).   
Taken together, the results suggest that Beclin 1 and Atg14L synergistically 
induce formation of specific structures on which autophagy protein Atg5, Atg12 and LC3 
are localized, and that they also synergistically promote the formation of double 
membranes during the process of autophagosome biogenesis.  
 
2.10 The functions of Rubicon 
2.10.1  Rubicon negatively regulates autophagy       
To study the possible functions of Rubicon on autophagy regulation, the Rubicon 
protein level was knocked down in NIH/3T3 cells with siRNA transfection, after which 
LC3 and p62/SQSTM1 protein levels were examined with western blot. Compared to 
control siRNA, Rubicon siRNA transfection reduced both LC3 I/II forms and 
p62/SQSTM1 levels, indicating that knockdown of Rubicon induced activation of 
autophagy, which resulted in elevated p62/SQSTM1 protein degradation and faster LC3 
I/II protein turnover by autophagy (Fig. 14a). When transfected cells were deprived of 
serum and amino acids, the same results were observed, indicating that when autophagy 
was induced by starvation, knockdown of Rubicon further activated autophagy (Fig. 14a). 





Figure 1-14. Rubicon is a negative regulator of autophagy 
(a) Rubicon RNAi knock-down in the NIH/3T3 cells led to decreased levels of 
p62/SQSTM1 and LC3 II  as detected with anti-p62/SQSTM1 and LC3 antibodies under 
both normal and starvation conditions. 
(b) Over-expression of Rubicon resulted in increased levels of p62/SQSTM1 under both 
normal and starvation conditions in both HEK293 cells stably expressing Rubicon-EGFP 
(upper panel) and HEK293T cells transiently transfected with Rubicon-EGFP (lower 
panel). The control cells were transfected with EGFP-N3 vector. 
(c) Vps34/PtdIns3K kinase activity assay. HEK293T cells were co-transfected with Myc-
Vps34/PtdIns3K-Vps15 and FLAG-tagged Rubicon or empty vector, either in the 
absence or in the presence of Beclin 1-EGFP. Myc-tagged Vps34/PtdIns3K that was 
immunoprecipitated using anti-Myc antibody was used for in votro kinase activity assay. 
The resulting radioactive PtdIns(3)P was separated by thin layer chromatography (TLC) 
and visualized by radiograph. The amount of radioactive PtdIns(3)P was normalized 
against the amount of immunoprecipitated Myc-tagged Vps34/PtdIns3K.  
(d) The results were quantified and showed that in the absence of Beclin 1, overexpessed 
Rubicon significantly reduced Vps34/PtdIns3K kinase activity (ratio=0.58, p=0.04 for the 
one-tailed Student’s t-test with unequal variances, n=4, labeled by asterisk). No 
significant difference was observed when Beclin 1 was co-transfected. 
(e) Starvation increased interaction between Rubicon and Beclin 1. HEK293T cells were 
transiently transfected with Atg14L-EGFP or Rubicon-EGFP. Cells were either 
maintained in complete media or under starvation conditions for 4 hours. After that 
immunoprecipitation was performed using anti-GFP antibody. Anti-Beclin 1 and anti-
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of Rubicon over-expression on autophagy levels was studied in transiently transfected 
HEK293T cells or in HEK293 cells stably expressing Rubicon-EGFP. Compared to 
control conditions, under both normal culture conditions and starvation conditions, over-
expression of Rubicon-EGFP resulted in increased p62/SQSTM1 protein levels in both 
transiently transfected cells and stable cells, indicating that Rubicon indeed inhibits 
autophagy (Fig. 14b).   
 
2.10.2  Rubicon negatively regulates Vps34/PtdIns3K kinase activity 
Since Rubicon is associated with Beclin 1-Vps34/PtdIns3K complex, its 
inhibitory effect on autophagy may be through regulation of Vps34/PtdIns3K kinase 
activity. To test this possibility, Myc-Vps34/PtdIns3K-Vps15 was co-transfected with 
either empty pCMV-FLAG vector or FLAG-Rubicon, and immunoprecipitated Myc-
Vps34/PtdIns3K was used for in vitro kinase activity assay (Fig. 14c). Compared to 
control condition, co-transfection of FLAG-Rubicon significantly reduced the kinase 
activity of Myc-Vps34/PtdIns3K. Interestingly, when Beclin 1-EGFP was also over-
expressed in the cells, this reduction of kinase activity largely diminished, indicating that 
Beclin 1 is not required for and furthermore interferes with the negative regulation of 
Vps34/PtdIns3K by Rubicon (Fig. 14c&d). 
 
2.10.3  Interaction between Beclin 1 and Rubicon increases under starvation conditions 
Rubicon reduces the interaction between Beclin 1 and Vps34/PtdIns3K (Fig. 10a), 
while Beclin 1 inhibits Rubicon’s regulation on Vps34/PtdIns3K (Fig. 14c&d). To 
characterize the possible function of Beclin 1-Rubicon interaction in autophagy, how 
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activation of autophagy affects this interaction was examined. To do this, HEK293T cells 
transfected with Rubicon-EGFP were either maintained in normal culture media or 
subjected to nutrient and amino acid starvation for 4 hours. Immunoprecipitation using 
anti-GFP antibody was then performed and immunoprecipitated endogenous Beclin 1 and 
Vps34/PtdIns3K were detected with western blot. Under starvation conditions, Rubicon-
EGFP pulled down significantly larger amount of Beclin 1 and Vps34/PtdIns3K, 
indicating that they have much stronger binding when autophagy is activated (Fig. 14e). 
In contrast, the interaction between Atg14L and Beclin 1 or Vps34/PtdIns3K showed no 
changes under starvation conditions (Fig. 14e). 
 
2.10.4  Rubicon blocks autophagosome acidification and maturation 
Vps34/PtdIns3K functions at various steps of intracellular membrane trafficking. 
In order to identify which step of autophagy may be affected by Rubicon, a previously 
developed double-tagged LC3 reporter, mCherry-GFP-LC3, was used to examine the 
maturation of autophagosomes, such as autophagosome acidification following fusion 
with late endosomes/lysosomes (Pankiv et al., 2007). Immature autophagosoms labeled 
with mCherry-GFP-LC3 emit both GFP and mCherry fluorescence and will appear 
yellow when two channels are merged under fluorescence microscope. However, since 
GFP is pH sensitive and cannot emit green fluorescence in acidic environments, 
mCherry-GFP-LC3 labeled mature autophagosomes that have fused with late 
endosomes/lysosomes will only show red color (Fig. 15a). In Hela cells co-transfected 




Figure 1-15. Rubicon blocks autophagosome maturation 
(a) Schematic representation of mCherry-GFP-LC3 construct. pH Neutral 
autophagosome will appear yellow under fluorescence microscope while mature 
autophagsomes that have fused with lysosomes will appear red. 
(b) Effect of over-expressing FLAG-Rubicon on autophagosome acidification, as 
monitored by mCherry-GFP-LC3 fluorescence. HeLa cells were transiently co-
transfected with mCherry-GFP-LC3 and FLAG-Rubicon (or control FLAG vector). Cells 
co-expressing mCherry-GFP-LC3 and control FLAG vector contained many red-only 
puncta along with yellow (indicating presence of both red and green) puncta, suggesting 
both autolysosomes and nascent autophagosomes (upper panel). In contrast, cells co-
expressing mCherry-GFP-LC3 and FLAG-Rubicon contained primarily yellow puncta, 
suggesting only nascent autophagosomes (lower panel, white arrows). Notably, some 
cells that did not express detectable levels of FLAG-Rubicon contained many red-only 
puncta (low panel, yellow arrows).   
(c) Quantitation of the results in (b) showed that over-expressing FLAG-Rubicon 
drastically reduced the percentage of red-only puncta (mCherry-LC3) from 39% in the 
control FLAG vector-transfected cells to 2% in the FLAG-Rubicon-transfected cells 
(asterisk, p=2E-26, one-tailed Student’s t-test with unequal variances, n=30), indicating 























observed were yellow, indicating that most mCherry-GFP-LC3 labeled autophagosomes  
in the cells are immature, and only about 2% of the autophagosomes were mature (Fig. 
15b and 15c). In contrast, in cells that were co-transfected with empty pCMV-FLAG 
vector or those that did not express detectable levels of FLAG-Rubicon, a significantly 
higher number of red punctate structures, which represented mature autophagosomes, 
were observed (Fig. 15b and 15c). These results suggest that over-expression of Rubicon 
blocked autophagosome acidification or maturation.  
Taken the above results together, it can be concluded that Rubicon negatively 
regulates autophagy and that it may be functioning through negatively regulating 
Vps34/PtdIns3K kinase activity and inhibiting autophagosome maturation. 
 
2.10.5  Over-expression of Rubicon causes aberrant expansion of late endosomes/lysosomes  
In cells transiently transfected with Rubicon-EGFP or cells that stably express 
Rubicon-EGFP, localization of Rubion-EGFP on large numbers of punctate and vesicular 
structures was observed (Fig. 16a). Transient transfection of FLAG-Rubicon and staining 
with FLAG antibody confirmed that the localization pattern was unique to Rubicon and 
not due to EGFP tagging (data not shown). Some of these Rubicon-EGFP puncta were 
large in size and exhibited “ring” shapes (Fig. 16a, yellow arrows). To study the identity 
of these structures, Hela cells transiently transfected with Rubicon-EGFP were stained 
with a series of cellular organelle markers. The results showed that the Rubicon-EGFP 
structures were primarily positive for Lamp1, a late endosome/lysosome larker, although 




Figure 1-16. Over-expressing Rubicon causes aberrant expansion of late 
endosomes/lysosomes 
(a) Co-localization of Rubicon-EGFP-associated structures (green) with the late 
endosome/lysosome marker Lamp1 (red, upper panel) (arrows) and partial co-localization 
of Rubicon-EGFP-associated structures (green) with the MVB marker LBPA (red, lower 
panel) (arrows) in the HeLa cells that were transfected with Rubicon-EGFP. Note that 
some of the Rubicon-EGFP-associated structures displayed “ring”-shape (yellow arrows). 
Scale bar: 10 m.  
 (b) Representative ultrastructural images show aberrant expansion of late 
endosomes/lysosomes structures in the HEK 293T cells over-expressing Rubicon-EGFP. 
These abnormal organelles are large in size and contained high (orange arrows) or low 
(black arrows) electron density. Some enclose small vesicles (purple arrows) and some 
resemble MVB (blue arrows). Scale bars: 500 nm. 
(c) Representative ultrastructural images showing late endosome/lysosome-like structures 
that are labeled by anti-GFP gold particles (panels 3-4) in the HEK 293T cells transiently 
transfected with Rubicon-EGFP. These structures are enwrapped by double membranes 
(panel 4 inset) and co-labeled by anti-GFP (developed by DAB) and anti-Lamp1 (gold 
enhanced) (panels 5-7). Note that mitochondria are mostly negative for Rubicon-EGFP 
(panel 4). The negative controls are without antibody (panels 1-2). M – mitochondria. 
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data not shown). In addition, some of the structures were positively stained with an 
antibody against lysobisphosphatidic acid (LBPA) (Fig. 16b), an unusual eukaryotic lipid 
found only in multi-vesicular body (MVB). These results suggest that the function of 
Rubicon may also be related to endocytic pathway. In order to examine the Rubicon-
EGFP-labeled structures at ultra-structural levels, electron microscopy (EM) analyses 
were performed.  Under EM, many abnormally large-sized vacuoles (1-5m in diameter) 
were observed in Rubicon-EGFP-transfected cells (Fig. 16b). In contrast, these large 
structures were not observed in cells over-expressing EGFP, Atg14L-EGFP or Beclin 1-
EGFP (data not shown). Some of these large vacuoles contained high electron density 
(Fig. 16b1&2, orange arrows), characteristic of late endosomes/lysosomes; some had 
relatively less content with overall low electron density (more transparent), which may 
represent an early stage of endosomes (but with enlarged size) (Fig. 16b3, black arrows); 
interestingly, some contained numerous small vesicles of multiple-layers (Fig. 16b2&4, 
purple arrows), while others resembled multivesicular endosomal vesicles or MVB (Fig. 
16c1&2, blue arrows). To ensure that these large organelles under EM are the same 
structures as those observed under fluorescence microscopy (Fig. 16a), immuno-EM was 
performed using anti-GFP antibody and extensive staining by the gold particles on the 
large vacuoles was observed (Fig. 16c3&4). These gold particles were found primarily 
associated to the outside of the limiting membranes, although some were also inside the 
membranes (Fig. 16c3&4). In addition, the immuno-EM results also confirmed the co-
localization of Rubicon-EGFP and Lamp1 at ultrastructural level, as shown by extensive 
co-localization between anti-GFP antibody associated DAB and anti-Lamp1 antibody 
associated gold particles (Fig. 16d5-7). 
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2.10.6  C-terminal cysteine-rich domain is essential for Rubicon localization 
Rubicon-EGFP exhibited distinctive punctate and vesicular localization in both 
transiently  transfected  cells  and  stably  expressing  cells  (Fig. 16a and 17a). In order to 
identify which part of the Rubicon protein is critical for its intracellular localization, the 
localization pattern of previously generated deletion mutants of Rubicon (Fig. 5a) was 
studied in transiently transfected cells. When the N-terminal RUN domain was deleted, 
Rubicon(RUN)-EGFP was still localized on numerous punctate and vesicular structures, 
and this pattern was very similar to that of  full length Rubicon-EGFP. However, when 
the C-terminal cysteine-rich domain was deleted, Rubicon(C)-EGFP was localized 
diffusely throughout the whole cytosol, and no punctate or vesicular structures were 
observed. Furthermore, when both RUN and cysteine-rich domains were deleted, 
Rubicon(RUN&C)-EGFP showed the same diffuse pattern as Rubicon(C)-EGFP (Fig. 
17a). Therefore, the C-terminal cysteine-rich domain within Rubicon is essential for 
maintaining its intracellular localization and possibly its function as well. 
Bioinformatic analysis of Rubicon sequence revealed that the several cysteine 
residues within the C-terminal cysteine-rich domain are conserved in FYVE domain, a 
well-characterized motif specific for PtdIns(3)P binding (Fig. 17b) (Stenmark et al., 
2002). However, the sequence in Rubicon does not contain the key consensus sequences 
of typical FYVE domain, i.e., WxxD, R[R/K]HHCR and RVC (Fig. 17b, red bars). 
Moreover, Rubicon-EGFP from tansfected cell lysate failed to bind to PtdIns(3)P-
conjugated sepharose beads, indicating that unlike other FYVE domain containing 
proteins, Rubicon does not bind to PtdIns(3)P directly (data not shown). Nevertheless, 





Figure 1-17.  Over-expressed Rubicon is localized on PtdIns(3)P enriched-structures 
and this loczalization if cysteine-rich domain dependent 
(a) Subcellular localization of transiently transfected Rubicon-EGFP, Rubicon(RUN)-
EGFP, Rubicon(C)-EGFP or Rubicon(RUNC)-EGFP in HeLa cells. In contrast to 
punctate Rubicon-EGFP and Rubicon(RUN)-EGFP, Rubicon(C)-EGFP and 
Rubicon(RUNC)-EGFP were localized diffusely in the cytoplasm. Abbreviations: 
RUN – RUN domain deletion, C – cysteine-rich domain deletion. Scale bars: 10 m. 
(b) Local sequence alignment between the C-terminal cystein-rich domain of Rubicon 
and FYVE domains of several known FYVE-containing proteins. Rubicon does not 
possess the key consensus sequences of a typical FYVE domain, i.e., N-terminal WxxD, 
central R[R/K]HHCR and C-terminal RVC (indicated by red bars). 
 (c) Co-localization of the PtdIns(3)P-enriched lipid domain marker p40 (phox)-PX-
EGFP (green) and Rubicon-AsRed (red) on large punctate structures (arrows) in the co-
transfected HeLa cells (upper panels). Upon short treatment with 75 nM wortmannin 
(another PI-3K inhibitor) for 1 hour, while the PtdIns(3)P-enriched lipid domains 
disappeared, the Rubicon-AsRed-positive structures was maintained (lower panels). Scale 

























reporter, p40 (phox)-PX-EGFP, they showed extensive co-localization, suggesting that 
Rubicon associated structures are enriched in Vps34/PtdIns3K product PtdIns(3)P (Fig. 
17c upper panel) (Kanai et al., 2001) Therefore, although the cysteine-rich domain is 
different from the typical FYVE domain and it does not directly bind to PtdIns(3)P, it is 
still closely related to the function of Vps34/PtdIns3K. In order to determine if the 
cysteine-rich domain dependent punctate/vesicular localization of Rubicon also depends 
on Vps34/PtdIns3K function, the cells co-transfected with Rubicon-AsRed and 
p40(phox)-PX-EGFP were treated with a chemical PI-3 kinase inhibitor wortmannin. 
Wortmannin treatment effectively dispersed punctate localization of p40(phox)-PX-
EGFP, due to inhibition of Vps34/PtdIns3K activity. However the localization pattern of 
Rubicon-AsRed was not affected by wortmannin treatment, suggesting that formation of 
Rubicon-associated structures is not dependent on Vps34/PtdIns3K activity (Fig. 17c, 
lower panel). 
       
2.10.7  Beclin 1 is not essential for formation of Rubicon-associated structures 
 Although formation of the Rubicon-associated structures is not dependent on 
Vps34/PtdIns3K activity, it is still closely related to it, as was indicated by co-
localization of PtdIns(3)P reporter p40(phox)-PX-EGFP on these structures. It was shown 
that Rubicon negatively regulated Vps34/PtdIns3K kinase activity, and that presence of 
over-expressed Beclin 1 interfered with this regulatory effect. Since Rubicon was 
identified as a component of the Beclin 1-Vps34/PtdIns3K protein complex, the relation 
between Beclin 1 and the Rubicon associated structures was studied.  First, Beclin 1-







Figure 1-18. Rubicon-associated structures do not have Beclin 1 on them and are 
Beclin 1-independent 
(a-b) Absence of full-length Beclin 1 (a) or Beclin 1-CE mutant (b) (red) on the Rubicon-
EGFP-positive structures (green) in the HEK293 cells stably expressing Rubicon-EGFP. 
These cells were transiently transfected with either Beclin 1-AsRed (a) or FLAG-Beclin 
1-CE (b, i.e., the FLAG-tagged Beclin 1 mutant containing both CCD and ECD that 
mediate the Beclin 1-Rubicon interaction as shown in Fig. 4c). Scale bars, 10m. 
(c) The formation of the Rubicon-EGFP-positive structures was Beclin 1 independent. 
HEK293 cells stably expressing Rubicon-EGFP were transfected with Beclin 1 siRNA. 
Although the endogenous Beclin 1 level was significantly knocked down, as was 
confirmed with western blot using Beclin 1 antibody, the formation of Rubicon-EGFP 































1-AsRed localized diffusely throughout the cytosol and no obvious co-localization of 
Beclin 1-AsRed on the Rubicon-EGFP associated structures was observed (Fig. 18a). 
This suggested that Beclin 1 may not be associated with the structures. To further 
confirm this, coiled-coil and evolutionary conserved domains (CE) of Beclin 1 were 
tagged with FLAG and transfected into Rubicon-EGFP stable cells. Previous co-
immunoprecipitation experiments showed that these two domains together mediate 
interaction between Beclin 1 and Rubicon (Fig. 4a&b). However, over-expressed FLAG-
CE showed no co-localizaiton on Rubicon-EGFP associated structures either. Finally, 
endogenous Beclin 1 protein level was knocked down with RNAi in Rubicon-EGFP 
stable cells to study whether Beclin 1 is required for formation of Rubicon associated 
structures. After siRNA transfection, endogenous Beclin 1 level was significantly 
reduced, as was confirmed with western blot. However the formation Rubicon-EGFP 
associated structures was not affected and comparable numbers of Rubicon-EGFP 
positive punctate and vesicular structures were observed in Beclin 1 siRNA transfected 
cells and control siRNA transfected cells (Fig. 18c). In conclusion, Beclin 1 is neither 















Figure 1-19. A hypothetic model for the Beclin 1-Vps34/PtdIns3K protein complexes 
and their functions 
In this model, a core Beclin 1 complex is composed of Vps34/PI-3K, p150/Vps15, Beclin 
1, UVRAG and likely substoichiometric Atg14L (indicated by the tight binding and 
functional connection between Atg14L and Beclin 1). Under physiological conditions, a 
large Beclin 1-Vps34 complex is formed, including the core complex and Rubicon. From 
this large complex smaller functioning complexes may form such as an Atg14L-Beclin 1-
containing complex and a Rubicon-containing complex. These smaller complexes are 
likely the functional units participating in autophagy regulation through modulating the 
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Generation and Characterization of beclin 1 Conditional Knockout 
Mice 
 
3.1 Generation of beclin 1 conditional knockout mice 
The beclin 1flox/flox mice were generated using bacterial artificial chromosome (BAC) 
recombination techniques in C57BL/6J strain background. The targeting BAC vector was 
generated so that two loxP sequences were inserted into the genome to flank the second 
exon of beclin 1 gene, where the start codon is located, and the neomycin resistant gene 
pGKneo cassette with two flanking FRT sequences were inserted into the intron region 
between the second and the third exons (Fig. 1a). Purified BAC DNA was electroporated 
into embryonic stem (ES) cells derived from C57BL/6J-Tyrc-2J/J mice, which are in 
C57BL/6J background but have white coat color due to a genetic mutation. After that 
cells were treated with G418 to select the ones that express the neomycin resistant gene. 
Two rounds of ES cell targeting were performed and overall 10 positive clones were 
obtained from screening 100 clones with southern blot. Further southern analysis 
confirmed that 8 within 10 clones were indeed positive clones in which homologous 
recombination happened in the correct way, resulting in an 8% targeting efficiency. 
Several positive clones were injected into C57BL/6J blastcyst, and chimera mice ranging 
from 5% to 40% were obtained. Successful germ line transmission from a 30% chimera 
mouse was confirmed with southern blot. After that the mice were crossed to transgenic 





Figure 2-1. Generation of beclin 1flox/flox mice 
(a) Schematic illustration of beclin 1 gene targeting construct. A modified bacterial 
artificial chromosome (BAC) clone was used as the targeting vector. Through 
homologous recombination, two loxP sites (black triangles) were inserted into the 
genome to flank the second axon of beclin 1, in which the start codon is located. The 
neomycin resistance gene pGKneo cassette was flanked by two FRT sites (black 
rectangles), and was later deleted by crossing to flipper mice. Southern blot to confirm 
correct recombination was performed using a probe that is located downstream of the 
homologous region B (arm B). 
(b) PCR reaction and southern blot of mouse genotyping. PCR reaction was performed on 
genomic DNA extracted from mouse tail clips. The primers used were located outside the 
inserted loxP sites, so that a bigger-sized band was generated when the loxP sites were 
successfully inserted into the genome. The southern blot was performed on BglII and 
SwaI digested genomice DNA from mouse tail clips. With an extra SwaI site introduced 
into the genome from homologous recombination, a shorter band was detected from the 
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ROSA26 (flipper mice) to remove the pGKneo cassette flanked by FRT sequences 
(Fiering et al., 1993). The resulted beclin 1flox/+ mice were crossed to each other to 
generate beclin 1flox/flox mice, and genotyping was performed using both polymerase chain 
reaction (PCR) and southern blot (Fig. 1b). Meanwhile, beclin 1flox/+ mice were also 
crossed to transgenic mice that express the Cre recombinase under the control of various 
cell type specific promoters to generate beclin 1flox/+; Cre mice (Nagy, 2000). Finally 
beclin 1 conditional knockout mice were generated by crossing beclin 1flox/flox mice with 
beclin 1flox/+; Cre mice to delete beclin 1 expression in different cell populations. 
 
3.2 Characterization of Beclin 1 function in Purkinje cells 
3.2.1  Deletion of Beclin 1 protein in beclin 1flox/flox; Pcp2-Cre Purkinje cells  
Beclin 1flox/flox mice were crossed to transgenic mice that express Cre recombinase 
under the control of Purkinje cell protein 2 (Pcp2, also known as L7) promoter (Pcp2-Cre) 
to delete beclin 1 expression in Purkinje cells. The Pcp2/L7 expression is restrict to 
Purkinje cells in the cerebellum and bipolar neurons in the retina (Oberdick et al., 1990). 
The gene expression starts from around postnatal day 2 (P2) and increases gradually to 
reach its peak at P15, and the Cre recombination driven by this promoter occurs between 
P15 and P19 (Nordquist et al., 1988; Komatsu et al., 2007a). To confirm that Beclin 1 
protein is successfully deleted in Purkinje cells, brain sections from beclin 1flox/flox and 
beclin 1flox/flox; Pcp2-Cre mice at the age of P21 were stained with anti-Beclin 1 antibody. 
In beclin 1flox/flox mice, the Purkinje cells showed clear staining, while in beclin 1flox/flox ; 
Pcp2-Cre mice the staining completely disappeared, indicating that Beclin 1 protein has 









Figure 2-2. Immunohistochemistry of Beclin 1 protein expression in Purkinje cells of 
beclin 1flox/flox and beclin 1flox/flox; Pcp2-Cre mice at P21 
(a) Beclin 1 protein was detected in beclin 1flox/flox Purkinje cells but not in beclin 1flox/flox; 
Pcp2-Cre Purkinje cells. Paraffin sections of the cerebella were stained with anti-Beclin 1 
antibody and visualization was performed with DAB. Scale bar: 100 m. 
(b) Floating sections from the same cerebella were stained with anti-calbindin antibody 
and fluorescein conjugated secondary antibody, showing that loss of Beclin 1 protein 
expression in  beclin 1F/F; Pcp2-Cre Purkinje cells was not due to loss of Purkinje cells. 













3.2.2  Degeneration of beclin 1flox/flox; Pcp2-Cre Purkinje cells 
To study if deletion of Beclin 1 induces any changes in Purkinje cells, sagittal 
brain sections from mice at different ages were first stained with an antibody against a 
Purkinje cell specific protein Calbindin. At P21, when the expression of beclin 1 has been 
deleted and no protein can be detected in Purkinje cells, Calbindin staining showed no 
significant difference in Purkinje cell number between beclin 1flox/flox; Pcp2-Cre mice and 
beclin 1flox/flox mice (Fig. 2, lower panel). However, by the age of 1 month, the Purkinje 
cell number in beclin 1flox/flox; Pcp2-Cre mice has dramatically decreased, and the 
remaining Purkinje cells also showed features of severe degeneration (Fig. 3a). In order 
to study whether there is area specificity in Purkinje cell degeneration, coronal cerebellar 
sections were stained with anti-Calbindin antibody. At 1 month, the degeneration was 
mainly in medial part of the cerebellum, where the biggest decrease in cell number was 
observed. Meanwhile the number of Purkinje cells in the lateral part of the cerebellum 
remained largely unchanged (Fig. 3b). By the age of 2 months, almost all of the Purkinje 
cells in the medial part had disappeared (Fig. 3c).  
 
3.2.3 Aberrant ultra-structures in early degenerating beclin 1flox/flox; Pcp2-Cre 
Purkinje cells 
In order to study the mechanism underlying the Purkinje cell degeneration in 
beclin 1flox/flox; Pcp2-Cre mice, sections of the cerebellum were first stained with 
autophagy and apoptosis markers. P62/SQSTM1 is an LC3 interaction protein that is 
degraded by autophagy, and its accumulation in the cells is often viewed as a hallmark of 








Figure 2-3. Degeneration of beclin 1flox/flox; Pcp2-Cre Purkinje cells 
(a) Sagittal sections of cerebella from 1 month old beclin 1flox/flox and beclin 1flox/flox; 
Pcp2-Cre mice were stained with anti-Calbindin antibody. Severe Purkinje cell loss was 
observed in beclin 1flox/flox; Pcp2-Cre mice. Scale bar: 500 m. 
(b) A coronal section of the cerebellum from a 1 month old beclin 1flox/flox; Pcp2-Cre 
mouse was stained with anti-Calbindin antibody. Severity of Purkinje cell degeneration 
showed area specificity. The medial region of the cerebellum showed more Purkinje cell 
loss than the lateral region. Scale bar: 500 m. 
(c) A sagittal section of the cerebellum from a 2 month old beclin 1flox/flox; Pcp2-Cre 
mouse was stained with anti-Calbindin antibody, showing that almost all Purkinje cells 












mice were stained with anti-p62/SQSTM1 antibody, no accumulation in the Purkinje 
cells was observed (data not shown). Meanwhile, anti-activated Caspase3 antibody 
staining did not detect any activated apoptosis in degenerating beclin 1flox/flox; Pcp2-Cre 
Purkinje cells (data not shown).  
To search for clues that can lead to possible mechanisms of degeneration of beclin 
1flox/flox; Pcp2-Cre Purkinje cells, electron microscopy (EM) study was performed. To 
catch the initial stage of the degeneration, a relatively early age (P21) was chosen, and 
both Purkinje cell bodies and axons in the deep cerebellar nuclei region were examined 
since neuronal degeneration often starts from the axon region. Semi-thin cerebellar 
sections (0.5m) were first cut and stained with Toluidine Blue, and Purkinje cells that 
showed darker staining than average (and therefore may be the ones undergoing early 
degeneration) were chosen for further morphological study under EM. In Purkinje cell 
bodies of beclin 1flox/flox; Pcp2-Cre mice, numerous electron dense structures were 
observed, and similar structures were rarely detected in Purkinje cells from control beclin 
1flox/flox mice. From the localization pattern, the electron dense structures could be divided 
into two types. One type appeared attached to intracellular membranes although the 
structures varied in size. Some were about 100nm in diameter, and were attached to Golgi 
or ER like membranous structures (Fig. 4a&b, bold red arrows); some were smaller in 
size and were associated with mitochondrial membranes (Fig. 4b&d, red arrowheads); 
and others were sheet-like structures that extended to longer than 0.5m and were tightly 
attached to mitochondrial membranes (Fig. 4a&c, red arrowheads). Interestingly, some of 
these structures looked like extended tips budding off Golgi or ER membranes that 








Figure 2-4. Abnormal ultra-structures in degenrating beclin 1flox/flox; Pcp2-Cre 
Purkinje cell bodies 
P21 beclin 1flox/flox; Pcp2-Cre Purkinje cell bodies were examined with electron 
microscopy, and numerous electron dense structures were observed. Some were small in 
size and were associated with either Golgi-like structures (a & b, bold red arrows), 
mitochondria (b, red arrowhead) or nuclear envelop (d, green arrowhead); some were in 
elongated shape and were attached to mitochondria (a & c, red arrowhead); and some 
looked like condensed tips of Golgi-like membranous structures (b, thin red arrows). In 
addition to membrane associated small structures, organelle-resembling large structures 
were also observed (b, c & d, green arrows). Meanwhile, late stage degenerating Purkinje 



























associated with cytosolic membranes, there were also cases when some structures were 
associated with the nuclear envelop (Fig. 4d, green arrowhead). In addition to these 
membrane associated structures, there was another type of electron dense structures that 
were much bigger in size (200nm~ in diameter) and not obviously associated with 
membranes (Fig. 4b&d, green arrows). Unlike the first type, which appeared to be from 
condensation of membranes, the second type of structures appeared more likely to be 
accumulation of electron dense materials in intracellular organelles. In some cases, 
organelles containing partially electron dense materials were observed, possibly 
representing an earlier stage in formation of such structures (Fig. 4c, green arrow).  
Meanwhile, Purkinje cells at late stages of degeneration were occasionally 
observed under EM (Fig. 4e). The condensed cell body and nuclear resembled features of 
apoptotic cell death, although staining the cerebellum sections with activated Caspase 3 
antibody did not yield any positive signal (data not shown). 
Abnormal structures were also observed in Purkinje cell axons in the deep 
cerebellar nuclei region of the cerebellum. Purkinje cells send axons to form synapses on 
deep cerebellar nuclei, and in many case axons can be the first area where degeneration is 
observed. When deep cerebellar nuclei region of beclin 1flox/flox; Pcp2-Cre mice was 
examined under EM, membranous structures were observed in myelinated axons and 
similar structures were not detected in control mice (Fig. 5a, arrowheads). Under higher 
magnification, these structures sometimes appeared to be repeatedly folded long 
membranes that took either regular shape (Fig. 5b) or irregular shape (Fig. 5c), and 









Figure 2-5. Abnormal ultra-structures in degenerating beclin 1flox/flox; Pcp2-Cre 
Purkinje cell axons 
The deep cerebellar nuclei region of a beclin 1flox/flox; Pcp2-Cre mouse was examined 
with electron microscopy. Abnormal membranous structures were observed in 
myelinated or unmyelinated axons (a, red arrowheads). The structures were regular or 
irregular in shape and seemed connected to the mitochondria outer membranes (b & c, 
red arrows). In some cases coated vesicles that resembled clathrin coated vesicles were 
















clathrin coated vesicles (Fig. 5d). In most cases, such structures were adjacent to the 
mitochondria that are often observed in normal myelinated axons, and interestingly 
sometimes the structures seemed to be connected to the outer membranes of the 
mitochondria (Fig. 5b&c, arrows). 
 
3.2.4  Deletion of Beclin 1 induces localization change of PtdIns(3)P in Purkinje cells 
In C. elegans, deletion of beclin 1 ortholog bec-1 caused disappearance of 
PtdIns(3)P, which is the product of C. elegans class III PI3-kinase LET-512/Vps34, from 
cytoplasmic membranes and vesicles in larvae (Takacs-Vellai et al., 2005). To test if 
deletion of beclin 1 in mice has similar effect, immuno-staining was performed on slices 
of the cerebellum from P21 mice using anti-PtdIns(3)P antibody. In beclin 1flox/flox 
Purkinje cells, PtdIns(3)P showed punctate localization, while in beclin 1flox/flox; Pcp2-Cre 
Purkinje cells its localization became much less confined and was diffuse throughout the 
whole cytoplasm. Therefore deletion of beclin 1 changed the localization pattern of 
PtdIns(3)P from possibly membrane and vesicle bound to largely cytoplasmic. 
In summary, deletion of Beclin 1 in Purkinje cells resulted in fast and severe cell 
degeneration, although the mechanism underlying the degeneration is not clear. Staining 
with autophagy and apoptosis markers showed that neither of them was activated, 
therefore the Purkinje cell death may be through alternative pathways, and may be related 












Figure 2-6. Localization change of PtdIns(3)P in beclin 1flox/flox; Pcp2-Cre Purkinje 
cells 
(a) Immuno-staining with anti-PtdIns(3)P antibody showed that in beclin 1flox/flox Purkinje 
cells PtdIns(3)P was localized on punctate and vesicular structures that were possibly 
early endosomes and multivesicular endosomes. 
(b) Anti-PtdIns(3)P antibody staining on beclin 1flox/flox; Pcp2-Cre Purkinje cells showed 
that the localization of PtdIns(3)P produced was more diffuse and localized throughout 

















3.3 Characterization of Beclin 1 function in cortical and hippocampal neurons 
3.3.1  Beclin 1 expression is reduced in cortical and hippocampal tissues in 
beclin 1flox/flox; EMX-Cre mice 
Beclin 1flox/flox mice were crossed to transgenic mice that express Cre recombinase 
under the control of EMX promoter (EMX-Cre) to delete beclin 1 expression in cortical 
and hippocampal neurons. The expression of EMX gene and the recombination driven by 
its promoter both start from early embryonic stage (Guo et al., 2000). Compared to beclin 
1flox/flox mice, beclin 1flox/flox; EMX-Cre mice showed reduced body sizes from as early as 
P15, and this difference persisted along development (Fig. 6a). Compared to beclin 
1flox/flox mice that rarely showed early death, mortality was observed in beclin 1flox/flox; 
EMX-Cre mice from the age of 6 weeks, and almost all mice died by the age of 2 months.  
To confirm that Beclin 1 protein level is reduced due to deletion of the gene, the 
cortex and hippocampus region of the brain was dissected out from a beclin 1flox/flox; 
EMX-Cre mouse and a beclin 1flox/flox mouse at P25, and lysates were prepared. Western 
blot with anti-Beclin 1 antibody showed that compared to the level in control mouse, the 
Beclin 1 protein level in the beclin 1flox/flox; EMX brain lysate was significantly lower 
(Fig. 6b).  
       
3.3.2  Accumulation of p62/SQSTM1 protein in beclin 1flox/flox; EMX-Cre neurons 
In cultured NIH/3T3 cells, knockdown of Beclin 1 protein level with RNAi 
resulted in changes in autophagy level and accumulation of p62/SQSTM1 protein in the 
cells. In order to study if loss of Beclin 1 induces the same changes in cortical and 










Figure 2-7. Reduced body size of beclin 1flox/flox; EMX-Cre mice 
(a) Beclin 1flox/flox; EMX-Cre mice showed reduced body size at P15, and by 1 month, the 
body size of beclin 1flox/flox; EMX-Cre is only about half of beclin 1flox/flox mice. 
(b) Reduced Beclin 1 protein level in beclin 1flox/flox; EMX-Cre cerebral cortex. Lysates 
from P25 beclin 1flox/flox and beclin 1flox/flox; EMX-Cre cerebral cortex tissues were used 
for western blot against anti-Beclin 1 antibody. Beclin 1 protein level was significantly 


























As a result, strong accumulation of p62/SQSTM1 was observed in beclin 1flox/flox; EMX-
Cre hippocampal pyramidal cells in CA1-CA3 area at P12 (Fig. 7a). Such accumulation 
occurred in the cytosol (Fig. 7b), and was not observed in dendate gyrus neurons or in 
beclin 1flox/flox mice (Fig. 7a and data not shown). This suggested that deletion of Beclin 1 
in hippocampal pyramidal cells may have impaired autophagy and caused accumulation 
of p62/SQSTM1 that failed to be degraded by autophagy.  Despite intracellular 
accumulation of p62/SQSTM1, with anti-NeuN antibody staining, the pyramidal cells in 
CA1-CA3 areas in beclin 1flox/flox; EMX-Cre mice showed comparable cell density to 
beclin 1flox/flox mice at P12 (Fig. 7a). However by P15 the cell density in these areas had 
greatly decreased and p62/SQSTM1 accumulation was still observed in many of the 
remaining pyramidal cells (Fig. 7c).  
Accumulation of p62/SQSTM1 was also observed in cortical neurons of beclin 
1flox/flox; EMX-Cre mice. At P12, only scattered neurons in the pre-frontal area of the 
cortex showed accumulation (Fig. 8a), and like in hippocampal pyramidal cells, the 
accumulation was in the cytosol (Fig. 8b). By P15, the p62/SQSTM1 accumulation was 
observed in a large number of cortical neurons, and interestingly the majority of such 
neurons were within the top layers in the pre-frontal area (Fig. 8c). Similar pattern was 
observed in P21 cortex as well (Fig. 8d). However, by the age of one month, 
p62/SQSTM1 accumulation in the cortex had become less obvious, with only scattered 
neurons showing accumulation again, and the number of such neurons further decreased 











Figure 2-8. Accumulation of p62/SQSTM1 protein in beclin 1flox/flox; EMX-Cre 
hippocampal pyramidal cells 
(a) At P12, strong accumulation of p62/SQSTM1 protein was observed in pyramidal cells 
within CA1 area of the beclin 1F/F; EMX-Cre hippocampus. Scale bar: 100m 
(b) The p62/SQSTM1 protein was accumulating in the cytosol of the pyramidal cells. 
Scale bar: 20m 
(c) At P15, strong accumulation of p62/SQSTM1 protein still remains in beclin 1flox/flox; 
EMX-Cre hippocampal pyramidal cells. The decreased density of neurons suggested the 














3.3.3  Activation of Caspase3 in beclin 1flox/flox; EMX-Cre mice 
By P15, the density of CA1-CA3 area hippocampal pyramidal cells have 
decreased significantly in beclin 1flox/flox; EMX-Cre mice (Fig. 7c). In order to study the 
possible mechanism underlying the neuronal degeneration, brain sections from beclin 
1flox/flox; EMX mice were stained with antibody against activated Caspase3 to study 
whether there was activation of apoptotic pathway. At P12 when there was strong 
accumulation of p62/SQSTM1 in CA1 hippocampal pyramidal cells, no obvious 
activated Caspase3 signal was observed in that area (data not shown). This is consistent 
with the observation that the cell density in that area was comparable to control mice at 
that age. At P15, when the cell density had greatly decreased, strong activated Caspase3 
signal was observed in the CA1-CA3 area but not in the dentate gyrus of the 
hippocampus in beclin 1flox/flox; EMX-Cre mice, or in control beclin 1flox/flox mice (Fig. 9a 
and data not shown). The activation of Caspase3 reached its peak at P21, as indicated by 
the massive antibody staining, and gradually decreased after that (Fig. 9b). By the age of 
6 weeks, activated Caspase3 signal was still able to be observed in the hippocampus (Fig. 
9c). 
In contrast to hippocampus where strong activated Caspase3 signal was observed, 
the signal from the cerebral cortex was much weaker and only very few cells in the cortex 
showed activation of Caspase3 at P15 (Fig. 10a). By P21, the number of such cells 
increased and they were mainly distributed in the upper to middle part of layer V of the 
cortex (Fig. 10b). By the age of 6 weeks, Caspase3activation spread to a wider area 
within the cortex: signal was also observed in layer II/III in addition to layer V (Fig. 10c). 








Figure 2-9. Accumulation of p62/SQSTM1 protein in beclin 1flox/flox; EMX-Cre 
cortical neurons 
(a) At P12, accumulation of p62/SQSTM1 protein was observed in scattered pyramidal 
neurons within pre-frontal area of the beclin 1flox/flox; EMX-Cre cerebral cortex. Scale bar: 
100m 
(b) The p62/SQSTM1 protein was accumulating in the cytosol of the pyramidal neurons. 
Scale bar: 20m 
(c-d) At P15 (c) and P21 (d), strong accumulation of p62/SQSTM1 protein was observed 
in the top layer (layer II/III) neurons of the beclin 1F/F; EMX-Cre cerebral cortex. In 
















of apoptotic pathway peaked at P21, it gradually increased within the cerebral cortex and 
showed different layer specificity at different ages. 
 
3.3.4 Aberrant ultra-structures in degenerating beclin 1flox/flox; EMX-Cre  
hippocampal pyramidal cells 
To further characterize the degeneration of beclin 1flox/flox; EMX-Cre hippocampal 
pyramidal cells, electron microscopy was performed. CA1 area in P12 mice was 
examined because at this age there was severe accumulation of p62/SQSTM1 protein in 
this area in beclin 1flox/flox; EMX-Cre cells while the overall cell density was comparable 
to that in control mice. Therefore degeneration is still at early stage. 
As a result, a large number of electron dense structures and aberrant membranous 
structures were observed in beclin 1flox/flox; EMX-Cre hippocampal pyramidal cells but 
not in control cells (Fig. 2-12). Under EM, some pyramidal cells showed severe 
degeneration and reduced sizes (Fig. 2-12a, arrowheads). In these cells, large electron 
dense structures were observed and they occupied almost all the remaining cytoplasmic 
area of the shrinking cells (Fig. 2-12a&b, asterisks). These structures often had 
concentric membranous structure next to or even connected to them (Fig. 2-12b, 
arrowheads). In other cells that showed relatively normal sizes, early accumulation of 
smaller electron dense structures was observed (Fig. 2-12a, area boxed in red and 
enlarged in Fig. 2-12c). Accumulation possibly started from aberrant less electron dense 
structures that were widespread in the cytoplasm (Fig. 2-12c&d, asterisk), and they 










Figure 2-10. Activation of Caspase3 in beclin 1flox/flox; EMX-Cre hippocampus 
(a) At P15, staining with antibody against activated caspase3 showed strong signal in 
CA1 and CA3 areas of the beclin 1flox/flox; EMX-Cre hippocampus. Meanwhile, the cell 
density in these areas was greatly reduced. Scale bar: 100m 
(b) Stronger signal of activated caspase3 was observed at P21 in beclin 1flox/flox; EMX-
Cre hippocampus, and cell density further decreased. Scale bar: 100m 
(c) At the age of 6 weeks, massive activation of caspase3 in beclin 1flox/flox; EMX-Cre 
hippocampus was still observed, although the intensity was lower compared to that at P21. 














Meanwhile, double membrane vesicles containing electron dense materials were often 
observed in these cells (Fig. 2-12c, arrows). In some cells, membrane sacs that were 
possibly in the process of enwrapping electron dense structures (Fig. 2-12d, arrowhead) 
and newly formed double membrane vesicles (Fig. 2-12d, arrow) were observed. In some 
other cells, fusion among the small electron dense structures was observed (Fig. 2-12e, 
arrowheads), and continued fusion of this kind likely accompanied cell degeneration and 
ultimately generated the large structures observed above (Fig. 2-12a&b, asterisks). 
Furthermore, these large electron dense structures would fuse with surrounding 
concentric membranous structures (Fig 2-12f, asterisk).  
In summary, deletion of Beclin 1 in cortical and hippocampal pyramidal cells 
resulted in intracellular accumulation of p62/SQSTM1 protein and activation of Caspase3, 
suggesting that autophagy in the neurons was disrupted and apoptotic pathway was 
activated. Furthermore, accumulation p62/SQSTM1 was observed and peaked at earlier 
ages than activation of Caspase3, suggesting that it preceded and might have been one of 
the reasons that caused activation of apoptotic pathway. A large number of electron dense 
structures and abnormal membranous structures were observed in degenerating beclin 
1flox/flox; EMX-Cre hippocampal pyramidal cells, suggesting that similar to the 
degeneration of beclin 1flox/flox; Pcp2-Cre Purkinje cells, the degeneration of pyramidal 
cells may also be related to disrupted intracellular vesicle formation or trafficking. 
Interestingly, neither p62/SQSTM1 accumulation nor Caspase3 activation was detected 
in beclin 1flox/flox; Pcp2-Cre Purkinje cells. Moreover, the electron dense structures 
observed in Purkinje cells and in pyramidal cells were not identical. This suggests that in 









Figure 2-11. Activation of Caspase3 in beclin 1flox/flox; EMX-Cre cerebral cortex 
(a) At P15, only very few cells in the  beclin 1flox/flox; EMX-Cre cerebral cortex showed 
activated caspase3 signal. Scale bar: 100m 
(b) Stronger signal of activated caspase3 was observed at P21 in beclin 1flox/flox; EMX-
Cre cerebral cortex, and cells that showed activation of caspase3 were mainly distributed 
in the middle part (layer V) of the cortex, showing layer specificity. Scale bar: 100m 
(c) At the age of 6 weeks, activation of caspase3 was no longer restricted to layer V and 
more cells in upper layers of the beclin 1flox/flox; EMX-Cre cerebral cortex was showing 














pyramidal cells may activate different pathways and react in different manners, although 
ultimately they all end up in degeneration.    
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Figure 2-12. Aberrant ultra-structures in degenerating beclin 1flox/flox; EMX-Cre 
hippocampal pyramidal cells 
(a) Under electron microscopy, some P12 beclin 1flox/flox; EMX-Cre hippocampal 
pyramidal cells showed features of late stage degeneration (arrowheads). Large-sized 
electron dense structures were observed and occupied almost all the cytoplasmic area of 
these cells. The area boxed in red is enlarged in (c). Scale bar: 5m.  
(b) Higher magnification image of one degenerating neuron in (a). Concentric 
membranous structures (arrowheads) were observed next to and connected to the large-
sized electron dense structure. Scale bar: 1m. 
(c) Enlarged image of the area boxed in red in (a). A large number of widespread less 
electron dense structures (asterisk), many round shaped more electron denser structures 
(arrowheads), and double membrane-enwrapped vesicles (arrows) were observed in the 
cytoplasm of a neuron that was at a relatively early stage of degeneration. Scale bar: 
500nm 
(d) Another example of early stage degenerating neurons. An isolation membrane sac 
was about to enwrap a small electron dense structure (arrowhead). Nearby, there was a 
newly formed double membrane vesicle containing electron dense materials (arrow). 
Scale bar: 500nm. 
(e) Possible fusion among small electron dense structures to form the large-sized 
accumulation bodies shown in (a) and (b). Scale bar: 500nm. 
 (f) A late stage degenerating neuron, in which the multiple-membrane structures 




























Chapter IV  
Discussion 
4.1 Identification of Beclin 1 interaction proteins 
A rescued mouse was generated and used for identification of Beclin 1 interaction 
proteins in this study. Under the endogenous promoter and other possible regulatory 
elements that were contained in the BAC, it could be estimated that expression of beclin 
1-EGFP followed loyally the expression pattern of the endogenous gene, and this was 
confirmed with staining tissue sections from Beclin 1-EGFP transgenic mice (Arsov et al., 
2008). Homozygous deletion of beclin 1 gene expression is embryonic lethal and the 
embryos die at around embryonic day 7.5 (E7.5). After crossing experiments, mice that 
have both beclin 1 alleles deleted but the transgene beclin 1-EGFP expressed (beclin 1-/-; 
beclin 1-EGFP, rescued mice) were born normally and the ratio of positive rescued pups 
to controls followed the Mendel’s law. The rescued mice showed no developmental 
abnormality, and further crossing experiments showed that they were also able to 
reproduce normally. Therefore it could be concluded that the rescue by Beclin 1-EGFP 
fusion protein was complete and the fusion protein possesses the physiological functions 
of the endogenous protein.  
In identifying interaction proteins, the rescued mice have several advantages over 
cultured cell lines, which are often used to over-express tagged proteins with transient or 
stable transfection. Over-expression of proteins in cultured cells is unphysiological, and 
often results in production of proteins at levels that are extremely high compared to their 
endogenous levels in vivo. As a result, the proteins produced may simply accumulate in 
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the cell without functioning properly, or may even start to interact with other proteins 
non-specifically. Furthermore, a certain protein may have different interaction partners in 
different tissues, and using a single cell type will not be able to identify all the possible 
interaction partners. In contrary to cell lines, the rescued mice provided a physiological 
environment for identification of interaction proteins. The level of fusion protein 
expression in the Beclin 1-EGFP transgenic mice is comparable to that of the endogenous 
protein, therefore no excess of fusion protein is created and non-specific binding is 
unlikely. In addition, since both endogenous beclin 1 alleles are deleted, there is no 
competition between endogenous protein and the fusion protein for binding with 
interaction partners. As a result, all proteins that bind to endogenous Beclin 1 can be 
expected to bind to Beclin 1-EGFP instead and to be immunoprecipitated. Finally, driven 
by the endogenous promoter and regulatory elements, the Beclin 1-EGFP fusion protein 
is expressed ubiquitously in almost all tissue and cell types like endogenous Beclin 1. As 
a result, it will be possible to use different tissues to study if any identified interaction 
protein is a general one that most tissues share or is tissue-specific. 
Using the rescued mice, at least six interaction proteins were identified from brain, 
liver and thymus. This suggested that the identified proteins bind to Beclin 1 across 
different tissue types and therefore are likely to be involved in the general regulation of 
Beclin 1 function and possibly autophagy as well. Within the six proteins, 
Vps34/PtdIns3K, Vps15 and UVRAG are already known Beclin 1 interaction proteins. 
Vps34/PtdIns3K is the major binding partner of Beclin 1, and it was reported that all 
Beclin 1 protein within the cells is associated with Vps34/PtdIns3K. Meanwhile, Vps15 
is the activator essential for Vps34/PtdIns3K function and UVRAG has been shown to 
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directly bind to Beclin 1. From these three proteins it could be confirmed that the in vivo 
immunoprecipitation from rescued mouse tissues was successful.   
Interestingly, the seven bands (six interaction proteins and the Beclin 1-EGFP 
fusion protein itself) visualized with Coomassie blue staining showed different intensity. 
Beclin 1-EGFP, Vps34/PtdIns3K, Vps15 and UVRAG showed comparably strong 
intensity, while the intensity of Rubicon, Atg14L and Nrbf2 was much weaker. In vivo 
immunoprecipitation was repeated and the same pattern was always observed (data not 
shown). This suggests that the binding affinity among these proteins may be different: 
Beclin 1 may have stronger or more stable binding with Vps34/PtdIns3K, Vps15 and 
UVRAG than with Rubicon, Atg14L and Nrbf2. Another possibility is that the different 
intensity may reflect the stoichiometry of protein complex composition: Beclin 1 may 
bind to more Vps34/PtdIns3K, Vps15 and UVRAG than to Rubicon, Atg14L and Nrbf2. 
Surprisingly, although Beclin 1 was first identified as a Bcl-2 interaction protein, 
Bcl-2 was not identified from this study. Even western blot with Bcl-2 antibody failed to 
detect any Bcl-2 in the protein mixture from the in vivo immunprecipitation (data not 
shown). And the recently identified Beclin 1 interaction proteins Bif1 and Ambra1 were 
not identified either. The tissue lysates used in this study for in vivo immunoprecipitation 
was prepared under mild detergent condition, using Triton X100 at the final 
concentration of 0.2%. Under this condition, the pellet after centrifugation that was not 
used still contained a certain amount of Beclin 1 (data not shown). Therefore, it is likely 
that only some insoluble membrane-bound Beclin 1 is interacting with Bcl-2 and this is 
consistent with a previous report that unlike the major Beclin 1 interaction protein 
Vps34/PtdIns3K that is localized predominantly on endosomes and trans Golgi network 
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(Gillooly et al., 2000), Bcl-2 is localized mainly on the outer mitochondrial and ER 
membranes (Germain and Shore, 2003; Pattingre et al., 2005). Interestingly it has also 
been reported that full-length Beclin 1 does not interact with Bcl-2 in the yeast two-
hybrid system (Liang et al., 1998) and that the interaction between endogenous Beclin 1 
and Bcl-2 was not detected in certain cell lines (Zeng et al., 2006). Therefore this 
interaction may also be transient or unstable that only occurs under specific conditions 
and therefore was not detected from in vivo immunoprecipitation in this study. The same 
scenario may also be true for interaction between Beclin 1 and Bif1 or Ambra1. 
Moreover, although the interaction proteins identified in this study seem to be general 
ones that are shared by multiple tissues, the possibility can not be ruled out that Beclin 1 
may have tissue or cell type specific binding partners. Further thorough study focusing on 
specific tissues will be able to answer this question.  
 
4.2 Beclin 1 containing protein complexes in mammalian cells 
Three novel Beclin 1 interaction proteins Atg14L, Rubicon and Nrbf2 and three 
already known proteins Vps34/PtdIns3K, Vps15 and UVRAG were identified in this 
study. It is an interesting question how many protein complexes may exist in mammalian 
cells. In yeast Atg6p forms two distinctive protein complexes with either Atg14p to 
regulate autophagy, or with Vps38p to mediated CPY sorting (Kihara et al., 2001b). 
However forced expression of beclin 1 in yeast strains that are deficient in atg6 only 
restored autophagy but did not rescue the disrupted CPY sorting pathway (Liang 1999). It 
is not due to the stable protein expressed, and this defect persisted even when Vps38p 
 121
was over-expressed (Melendez et al., 2003). Therefore Beclin 1 may be able to 
functionally interact with Atg14p but not with Vps38p.  
It is not clear how many Beclin 1-containing protein complexes exist in 
mammalian cells and what their composition is. In this study, endogenous 
immunoprecipitation using Atg14L and Rubicon antibodies initially suggested that they 
might exist in different protein complexes, since they failed to pull down each other 
although they both were able to pull down Beclin 1 and Vps34/PtdIns3K. However, gel 
filtration from both wild type and rescued mouse tissues showed that Beclin 1, 
Vps34/PtdIns3K, Atg14L and Rubicon all eluted in the same fractions, although Atg14L 
and Rubicon both eluted in later fractions as well that may represent smaller protein 
complexes. This strongly suggests that all these proteins can co-exist in one same large 
protein complex, and this was confirmed from transient transfection and co-
immunoprecipitation experiments. Although the gel filtration experiment in this study 
was not able to show distribution of UVRAG, it should be reasonable to hypothesize that 
it also exists in this large complex given the fact that UVRAG and Beclin 1 bind directly 
to each other (Liang et al., 2006), and this hypothesis is supported by co-
immunoprecipitation as well. In addition to this large complex, it is possible that there are 
multiple smaller Beclin 1-related protein complexes in mammalian cells. Some 
complexes may contain only Atg14L while others may contain only Rubicon, which is 
consistent with the results from endogenous immunoprecipitation using Atg14L and 
Rubicon antibodies. These smaller complexes may be derived from the initial large 
complex, and may be the ones that actually mediate Beclin 1’s function.  
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4.3 Beclin 1-Atg14L interaction 
The protein Atg14L identified in this study showed moderate homology to yeast 
protein Atg14p, and the homology was shared mainly in the coiled-coil domain region 
that was shown to be essential for interaction between Beclin 1 and Atg14L. Like yeast 
Atg14p, Atg14L showed strong binding affinity to Beclin 1. Upon co-transfection 
Atg14L and Beclin 1 both changed intracellular localization pattern dramatically and 
became co-localized with each other completely. In yeast, Atg6p and Atg14p are both 
peripherally associated with membrane fractions, and pretreatment of cell extract with 
detergent did not disrupt the interaction between Atg6p and Atg14p, indicating that they 
are binding directly (Kametaka et al., 1998). Whether Beclin 1 and Atg14L bind to each 
other directly in mammalian cells was not characterized in this study and future binding 
assay using recombinant proteins will provide an answer to this question. In yeast, Atg6p 
is important for the stabilization of Atg14p, because Atg14p was barely detectable in 
Atg6 mutant cells (Kihara et al., 2001b). Similarly, in mammalian cells Beclin 1 is 
essential for stabilization of Atg14L too, since transfection of Beclin 1 siRNA resulted in 
significant decrease of Atg14L protein level. And in consistence with this, when Atg14L-
EGFP alone was transfected into cells, only dim fluorescence was observed, indicating 
the lack of abundance of the protein in the cells. However when Beclin 1 was co-
transfected, the fluorescent signal of Atg14L-EGFP became much stronger, possibly 
because more protein was stabilized through forming complexes with over-expressed 
Beclin 1.  
Atg14L also share some functional similarity with yeast Atg14p. Atg14L 
positively regulates both Vps34/PtdIns3K kinase activity and autophagy levels in the 
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cells, and co-transfection of Beclin 1 and Atg14L induced electron dense structures that 
were not observed in cells transfected with either Beclin 1 or Atg14L alone. Such 
structures were clearly not aggresomes that arose from over-production of proteins since 
they were surrounded by double membranes. Autophagy proteins that participate in 
autophagosome formation such as Atg5, Atg12 and LC3 were found co-localized on 
these structures, suggesting that these structures were possibly pre-autophagosomal 
structures (PAS) that Atg6p and Atg14p in yeast are localized on. Therefore it is likely 
that Beclin 1 and Atg14L function together to promote the initial steps of autophagosome 
formation. In consistence with this, co-transfection of Beclin 1 and Atg14L induced 
membrane rearrangement in the cells and increased number of autophagosomes were 
observed in the transfected cells.  
It is likely that Atg14L may promote autophagy levels by positively regulating 
Vps34/PtdIns3K kinase activity, and Beclin 1 is essential for this since only with co-
transfection of Beclin 1 did Atg14L increase the kinase activity of Vps34/PtdIns3K. 
Beclin 1 increased the binding between Atg14L and Vps34/PtdIns3K, and meanwhile, 
with the presence of Atg14L, Vps34/PtdIns3K was able to pull down more Beclin 1. 
Therefore Beclin 1 and Atg14L enable each other to form a more stable complex with 
Vps34/PtdIn3K and this complex that contains these three proteins and possibly Vps15 
may be one of the smaller functioning complexes, which promotes induction of 
autophagy and autophagosome biogenesis.  
However to determine whether Atg14L is truly the ortholog of yeast Atg14, a 
complement experiment showing that forced expression of Atg14L in Atg14 null yeast 
cells can restore the autophagy level will be necessary. And if that is the case, then the 
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yeast Atg6p-Atg14p-Vps34p-Vps15p sub-complex is also well conserved from yeast to 
mammalian cells like other autophagy proteins.  
Treatment of Bax/Bak-/- cells with Beclin 1 siRNA also reduced Atg5-Atg12 
protein levels (Shimizu et al., 2004), indicating that like Atg14L, protein stabilization of 
Atg5-Atg12 may also be dependent on Beclin 1. Therefore combining the data from this 
study, it can be concluded that Beclin 1 is genuinely a key protein in autophagy induction.  
 
4.4 The functions of Rubicon 
Atg6p forms a second protein complex in yeast with Vps38p, and whether 
Rubicon might be its mammalian ortholog was studied. However no homology was 
observed between Rubicon and Vps38p and there is very little functional similarity 
between Rubicon and Vps38p. Previous studies (Kihara et al., 2001b) show that Vps38p 
mediates interaction between Atg6p and Vps34p, since the interaction is disrupted in 
Vps38 mutant cells. However, Rubicon is showing a rather inhibitory effect on interaction 
between Beclin 1 and Vps34/PtdIns3K. Vps38p level is not detectable in Atg6 mutant 
cells, indicating that Atg6p is essential for Vps38p stabilization. When Beclin 1 protein 
level was knocked down with RNAi in NIH/3T3 cells, Rubicon protein level showed 
little change compared to control conditions. Moreover, deletion of Vps38 in yeast 
significantly reduced the PtdIns 3-kinase activity, indicating the positive regulatory 
function of Vps38p. On the contrary, Rubicon negatively regulates the kinase activity of 
Vps34/PtdIns3K. Therefore Rubicon is clearly not the mammalian ortholog of Vps38 and 
if a mammalian ortholog does exist it still remains to be identified.  
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In contrast to Atg14L, Rubicon negatively regulates autophagy, and it may also be 
through its negative regulation on Vps34/PtdIns3K kinase activity. Interestingly unlike in 
the case of positive regulation by Atg14L, this negative regulation is inhibited by Beclin 
1, since it diminished in the presence of over-expressed Beclin 1. Meanwhile, over-
expression of Rubicon decreased the amount of Vps34/PtdIns3K that Beclin 1 was able 
to bind, although Beclin 1 did not interfere with the binding between Rubicon and 
Vps34/PtdIns3K. Therefore Rubicon and Beclin 1 may be inhibitory on each other’s 
binding to Vps34/PtdIns3K, or may be competing to bind to it in an exclusive manner. 
And the inhibition of Rubicon’s negative regulation on autophagy by Beclin 1 may be 
part of the functions of Beclin 1 in promoting autophagy induction. Interestingly, in cells 
transiently transfected with Rubicon-EGFP, starvation induced significant increase of 
binding between Rubicon-EGFP and Beclin 1. This increase of binding may be important 
for starvation induced autophagy activation because it inhibits the negative regulation by 
Rubicon on Vps34/PtdIns3K and therefore results in a positive regulation.   
Over-expression of Rubicon resulted in massive abnormal vesicle structures that 
were labeled positive for late endosome/early lysosome marker LAMP1 and multi-
vesicular body marker LBPA, suggesting that Rubicon is likely to be involved in 
endocytic pathway in addition to its function in autophagy regulation. To test whether 
endocytosis is affected by over-expression or protein knock-down of Rubicon, horse 
radish peroxidase (HRP) intake and epidermal growth factor (EGF) induced receptor 
(EGFR) internalization was examined in cells transfected with either Rubicon-EGFP or 
Rubicon siRNA. In both cases, no significant difference was observed between Rubicon 
transfected cells and control cells. Therefore the internalization step of endocytosis 
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appears not significantly affected by Rubicon, and this is consistent with the observation 
that only a small number of Rubicon induced structures were positive for early endosome 
marker EEA1. Rubicon blocks autophagosome maturation, and the reason can be either 
that the fusion step of autophagosomes with lysosomes is inhibited, or that lysosomes 
themselves fail to develop normally. Therefore, the involvement of Rubicon in endocytic 
pathway may also be at a relatively late stage, such as maturation of endosomes and their 
fusion with lysosomes. 
The functions of Rubicon in endocytic pathway may also be closely related to 
Vps34/PtdIns3K. Although the C-terminal cysteine-rich domain of Rubicon is not 
identical to the FYVE domain and does not bind directly to PtdIns(3)P,  the product of 
Vps34/PtdIns3K, nevertheless they showed extensive co-localization. It is likely that 
Vps34/PtdIns3K binds to Rubicon and is localized on the Rubicon-associated structures, 
and therefore its product is enriched where Rubicon is localized. However co-transfection 
experiments showed that Beclin 1 is not co-localized on the Rubicon-associated 
structures. A previous report showed that knocking down Beclin 1 protein level in cells 
did not affect the endocytic pathway (Zeng et al., 2006). Moreover, in mammalian cells, 
quantitative analyses with a cross-linker showed that although all Beclin 1 is associated 
with Vps34/PtdIns3K complex, ~50% of Vps34/PtdIns3K is free of Beclin 1. And partial 
overlap between Vps34/PtdIns3K and late endosome/mutli-vesicular body (MVB) 
marker LBPA is observed (Kihara et al., 2001a). Therefore a small Rubicon functioning 
complex that contains Vps34/PtdIns3K but not Beclin 1 may exist on the Rubicon-
associated structures.  
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Both immunoprecipitation from wild type cells using anti-Rubicon antibody and 
immunoprecipitation from Rubicon-EGFP stable cells using GFP antibody showed that 
UVRAG binds to Rubicon but not to Atg14L. This suggested that UVRAG may be in the 
smaller functioning complex with Rubicon although anti-UVRAG antibody failed to 
detect clear signal from fractions collected from gel filtration. Interestingly, UVRAG has 
been shown to be closely related to autophagosome maturation and endocytic trafficking 
as well (Liang et al., 2008) However in that study, both endogenous and epitope-tagged 
UVRAG consistently showed colocalization with early endosomal marker EEA1 but not 
with late endosomal markers. Moreover, UVRAG was shown to facilitate autophagosome 
maturation and fusion of endosomes with lysosomes through its interaction with class C 
Vps complex, and Beclin 1 was not necessary for that function. Therefore Rubicon and 
UVRAG seem to function at similar steps of the same pathways, but in directly opposite 
directions. However this does not argue against the possibility that Rubicon and UVRAG 
may co-exist in the small functioning complex: their opposite functions may be important 
for keeping autophagy and endocytosis levels well balanced and under control in the cells. 
From the data of this study, a model can be proposed. There is a large Beclin 1 
protein complex that contains at least most of the Beclin 1 interaction proteins identified 
in this study: Vps34/PtdIns3K, Vps15, UVRAG, Atg14L and Rubicon. Within this large 
complex, Beclin 1, Vps34/PtdIns3K, Vps15 and UVRAG may be the core component 
given their similar stoechiometry as identified from the in vivo immunoprecipitation. 
Although Atg14L was detected at a much lower intensity, from its high binding affinity 
with Beclin 1, it is possible that Atg14L is also one of the core components. Multiple 
smaller protein complexes can be generated from this initial large complex and may be 
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the ones that actually function in various cellular pathways. One such complex contains 
Beclin 1, Vps34/PtdIns3K and Atg14L, and it functions at the initial step of autophagy 
and promotes antuphagosome biogenesis. Another complex contains Vps34/PtdIns3K 
and Rubicon, and may contain UVRAG as well but not Beclin 1. Its function is in 
inhibiting endocytic pathway and autophagosome maturation (Fig. 1-19). Through 
interaction with either Atg14L or Rubicon, Beclin 1 may be playing a critical role in 
regulating the balance of autophagy and thereby in maintaining the homeostasis of the 
cells.  
 
4.5 Function of Beclin 1 in autophagy and development  
Specific deletion of beclin 1 in several populations of neurons caused 
degeneration, and different cell types showed different phenotypes. In cortical and 
hippocampal pyramidal cells, deletion of beclin 1 induced intracellular accumulation of 
p62/SQSTM1, indicating that autophagy in these neurons was disrupted. Activation of 
apoptotic pathway and massive cell death were also observed. Interestingly, 
p62/SQSTM1 accumulation preceded the activation of apoptotic pathway and cell death 
by a few days, suggesting that the failure to degrade intracellular proteins might have 
been one of the reasons that induced apoptosis activation. It is also consistent with 
previous reports that deletion of Atg5 or Atg7 in the central nervous system induced 
inhibition of basal level of autophagy and caused accumulation of ubiquitinated proteins 
and activation of apoptosis (Hara et al., 2006; Komatsu et al., 2006).  
Electron microscopy studies revealed accumulation of electron dense structures in 
beclin 1-/-; EMX-Cre hippocampal pyramidal cells. The accumulation likely starts from 
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protein aggregates that fail to be degraded by autophagy, and gradually include aberrant 
membrane structures that are generated possibly also due to disruption of autophagy. The 
degeneration of the cells proceeds as the accumulation bodies grow, and at the late stages 
of degeneration, the accumulation bodies will likely occupy almost all the cytoplasmic 
area. Interestingly, a large number of double membrane vesicles that resembled 
autophagosomes were observed in beclin 1-/-; EMX-Cre hippocampal pyramidal cells, 
suggesting that the deletion of beclin 1 may not inhibit autophagosome formation but 
rather may block the clearance of autophagosomes. And this is consistent with the 
observation that knocking down Beclin 1 protein level in NIH/3T3 cells increased LC3II 
form level. Furthermore, it is also consistent with the functional interaction between 
Beclin 1 and its newly identified interaction protein Rubicon. Since Rubicon blocks 
autophagosome maturation and this activity may be inhibited by Beclin 1, deletion of 
beclin 1 may result in an increase in blocking of autophagosome maturation. Although 
studies have shown that Beclin 1 is essential for autophagy, its exact function is still 
unclear. Therefore further in vivo characterization of autophagy pathway in beclin 1-/-; 
EMX-Cre hippocampal pyramidal cells will provide important information.  
In contrast to cortical and hippocampal pyramidal cells, when beclin 1 was 
deleted in Purkinje cells, despite severe degeneration and massive cell loss, no obvious 
p62/SQSTM1 accumulation and activation of apoptosis was observed. Instead Purkinje 
cells at early stage of degeneration showed many electron dense structures that from their 
morphology seemed closely related to the intracellular membranes. Since Beclin 1 is part 
of the Vps34/PtdIns3K complex and the complex has important functions in membrane 
trafficking in the cells, it can be speculated that the phenotype induced by deletion of 
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beclin 1 may be related to Vps34/PtdIns3K function. In yeast, Atg6p is not essential for 
activation of Vps34p, since Atg6 mutant cells showed only a slight decrease in PtdIns 3-
kinase activity (~80% of wild type cells) (Kihara et al., 2001b). Similarly siRNA 
mediated knockdown of Beclin 1 in NIH/3T3 cells did not significantly affect the 
Vps34/PtdIns3K kinase activity in the cells (data not shown). Therefore, it is likely that 
Beclin 1 does not catalytically regulate Vps34/PtdIns3K activity but rather mediates its 
intracellular localization, possibly by selectively forming different small functioning 
protein complexes. Therefore deletion of beclin 1 in Purkinje cells may have induced 
aberrant localization of Vps34/PtdIns3K. Since Vps34/PtdIns3K has important function 
in membrane trafficking and lysosomal enzyme sorting, its mislocalization can result in 
defect in membrane genesis and lysosome development in the cells. Immuno-staining 
with anti-PtdIns(3)P antibody showed that deletion of beclin 1 induced changes in 
localization of PtdIns(3)P, the product of Vps34/PtdIns(3)K, in Purkinje cells. Future 
electron microscopy experiments using PtdIns(3)P probes such as tagged 2xFYVE 
domains will be performed to confirm the specific localization of PtdIns(3)P in both 
control and beclin 1-/-; Pcp-2 Cre Purkinje cells. Meanwhile, immuno-staining studies 
using lysosomal markers will be performed to examine whether there is abnormality in 
lysosome development and maturation in beclin 1-/-; Pcp-2 Cre Purkinje cells.  
Comparing the phenotypes of beclin 1 neuronal knockout mice and Atg5/Atg7 
neuronal knockout mice, some big differences can be immediately noticed. Atg7flox/flox; 
nextin-Cre mice can live as long as 28 weeks (Komatsu et al., 2004), while almost all 
beclin 1flox/flox; EMX-Cre mice, though with much more limited cell populations affected, 
die by 8 weeks. Atg7flox/flox; Pcp2-Cre mice don’t show severe Purkinje cell death until 
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P56 while in beclin 1flox/flox; Pcp2-Cre mice Purkinje cell degeneration starts from as early 
as P21 and by the age of one month almost half of the Purkinje cells are dead (Komatsu 
et al., 2007a). Similar difference exists between beclin 1-/- and Atg5-/-/Atg7-/- mice. Both 
Atg5-/- and Atg7-/- mice survive to be born while beclin 1-/- die at early developmental 
stage at E7.5 (Yue et al., 2003; Kuma et al., 2004; Komatsu et al., 2005). Therefore it is 
suggested that Beclin 1 has other critical function than just regulating autophagy and 
therefore is more important for development than other autophagy proteins. The results 
from this study suggest that Beclin 1 may also regulate membrane trafficking and 
lysosome development in the cells, possibly through interaction with Vps34/PtdIns(3)K. 
Future study focusing on this direction will likely provide useful information to help 













Methods and materials 
Reagents and antibodies 
Dynabeads M-270 epoxy, NuPAGE Bis-Tris gels, Western blot transfer buffer, 
MES SDS running buffer, antioxidant, Lipofectamine 2000 and Lipofectamine RNAi 
MAX kits were purchased from Invitrogen (Carlsbad, CA). Modified Trypsin, EDTA-
free protease inhibitor cocktail tablets, and FuGene 6 transfection reagent were purchased 
from Roche Diagnostics (Indianapolis, IN). Immobilon-P PVDF membrane was 
purchased from Millipore (Billerica, MA). GelCode Blue Stain Reagent, Trifluoroacetic 
acid, Tris(2-carboxyethyl)-phosphine hydrochloride, and the Micro BCA Protein Assay 
Reagent Kit were purchased from Pierce (Rockford, IL). Gel filtration calibrant mixtures 
were purchased from BioRad (Hercules, CA). Phosphatidylinositol was purchased from 
Avanti Polar Lipids (Alabaster, AL). Radio-active 32P-ATP was purchased from 
PerkinElmer (Waltham, MA). G418, anti-myc affinity gel beads, 3,3'-Diaminobenzidine 
(DAB) and urea tablets were purchased from Sigma (St Louis, MO). Beclin 1 siRNA was 
purchanse from Dharmacon (Lafayette, CO); Atg14L siRNA was purchased from 
Invitrogen (Carlsbad, CA); and Rubicon and control siRNA were purchased from 
Ambion (Austin, TX). Coated silica gel was purchased from EMD (Gibbstown, NJ). 
Fluorescence mounting medium was purchased from Abcam (Cambridge, MA). 
Vectastain Elite ABC kit was purchased from Vector Laboratories (Burlingame, CA). 
Commercial antibodies used in this study include rabbit polyclonal LC3 antibody 
(1:1000, MBL, Woburn, MA), rabbit polyclonal antibody raised against the C-terminal of 
UVRAG (1:500, Abgent, San Diego, CA), rabbit polyclonal Beclin 1 antibody (1:600; 
Santa Cruz Biotechnology, Santa Cruz, CA), guinea pig polyclonal p62/SQSTM1 
 133
antibody (1:1000, American Research Products, Inc., Belmont, MA), mouse monoclonal 
Lamp 1 antibody (1:10, Developmental Studies Hybridoma Bank at the University of 
Iowa, Iowa City, IA), mouse monoclonal LBPA antibody (1:200, Echelon Biosciences 
Inc. Salt Lake City, UT), rabbit polyclonal Vps34antibody (1:250, Zymed Laboratories, 
San Francisco, CA), mouse monoclonal syntaxin 6 antibody (1:600, BD Tranduction 
Laboratories, , San Jose, CA), mouse monoclonal EEA1 antibody (1:600, BD 
Tranduction Laboratories, San Jose, CA), mouse monoclonal protein disulphide 
isomerase (PDI) antibody (1:100, Abcam, Cambridge, MA), mouse monoclonal c-myc 
antibody (1:1000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA; Zymed Laboratories, 
San Francisco, CA), mouse monoclonal M2 FLAG and -actin antibodies (Sigma, St. 
Louis, MO), anti-rabbit Alexa Fluo 555 and Alexa 488 (1:1000, Invitrogen, Carlsbad, 
CA), Rhodomine red conjugated secondary antibody (Jackson ImmunoResearch, West 
Grove, PA), anti-mouse and anti-rabbit Cy5 (1:500, Zymed Laboratories, San Francisco, 
CA), rabbit IgG (1:6000; Amersham, Pittsburgh, PA), mouse IgG (1:10000; Pierce, 
Rockford, IL).  
Rabbit polyclonal GFP antibody was raised against GST-tagged GFP and affinity 
purified in house as described previously (Cristea et al., 2005). Rabbit polyclonal Atg14L 
and Rubicon antibodies were generated as described below. Full length cDNA of Atg14L 
was cloned into NdeI and BamHI sites of bacterial expression vector pET-28a(+) 
(Novagen, USA). Partial cDNA of Rubicon that corresponds to amino acids 220-941 was 
cloned into NheI and BamHI sites of pET-28a(+) vector. Recombinant 6 His-tagged 
Atg14L and Rubicon proteins were expressed in BL21-Codon-Plus (DE3)-RIL 
competent cells and purified with Ni-NTA agarose beads (Qiagen, USA). A total of 500 
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g of purified recombinant protein was used for injections to produce polyclonal 
antibodies in rabbits (Cocalico Biologicals, Inc. Reamstown, PA). Sera were either 
purified with protein-G column (GE Healthcare, Piscataway, NJ) (Rubicon) or further 
affinity purified with recombinant protein (Atg14L). 
 
Generation and genotyping of the Beclin1-EGFP BAC transgenic mice 
Beclin1-EGFP mice were generated using BAC mouse transgenic techniques 
(Gong et al., 2002). In brief, a 455-base pair homology region immediately upstream of 
stop codon of Becn1 gene (“A box”) was PCR amplified and inserted between AscI and 
SmaI sites of pLD53.SCA-E-B, and another 507-base pair homology region immediately 
downstream of stop codon was PCR amplified and inserted between PacI and StuI sites 
of the vector (“B box”) (Gong et al., 2002). Through homologous recombination, DNA 
sequence encoding EGFP protein followed by a stop codon was inserted into the BAC 
clone RP24-392C4 which contains all regulatory elements of Beclin 1 gene to replace the 
original stop codon of Beclin 1. The modified BAC clone was purified using CsCl 
gradient ultra-centrifugation, and used for pronuclear injection in FVB/NJ mice. All mice 
were backcrossed to C57BL/6J background for more than 10 generations before analysis. 
Genotype of mice from pronuclear injection was determined with either southern 
blot or PCR reaction. For southern blot, a 0.5 inch piece of mouse tail was clipped from 
the tail end and incubated in lysis buffer (27% sucrose, 1 SSC, 1 mM EDTA, 1% SDS, 
200 g/ml proteinase K) at 55°C overnight. After extractions with phenol:chloroform 
(1:1) and with chloroform, DNA was precipitated with ethanol and dissolved in TE buffer. 
Genomic DNA was digested with XhoI and XbaI, and was analyzed with southern blot 
 135
using “A box” as the hybridization probe. For PCR reaction, the EGFP forward and 




Generation of rescued mice 
Beclin 1-EGFP/+ transgenic mice were genetically crossed with beclin 1 +/– mice 
to generate rescued mice, in which both endogenous beclin 1 alleles are deleted and only 
beclin 1-EGFP transgene is expressed. First, beclin 1-EGFP mice were crossed with 
beclin 1 +/– mice to obtain beclin 1 +/–; beclin 1-EGFP mice. Then mice of this genotype 
were further crossed with beclin 1 +/– mice to obtain beclin 1 –/–; beclin 1-EGFP mice. 
Tails were clipped from mice and protein was extracted in protein lysis buffer (20mM 
HEPES, pH7.4/ 1mM MgCl2/0.25mM mM CaCl2/ 0.2% Triton X-100/150mM NaCl/ 
protease inhibitor and PMSF-pepstatin/DNaseI), after which western blot with anti-
Beclin 1 antibody was performed to confirm the deletion of endogenous Beclin1 protein. 
Multiple litters were produced and the numbers of mice of each genotype were counted to 
examine whether the Mendel’s law was followed. 
 
Affinity purification and mass spectrometric analysis 
Affinity purification of Beclin 1 interacting proteins and mass spectrometric 
identification of these proteins were carried out as described (Wang et al., 2006), with 
slight modification. In brief, tissue extracts were obtained from both Becn1+/– and Becn1–
/–; Becn1-EGFP mice (4 months of age) by homogenizing 2 brains or 1 liver with a 
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motor-driven homogenizer (speed 2.5, 12 strokes) in 4 ml buffer containing 0.32 M 
sucrose, 1 mM NaHCO3, 20 mM HEPEs/pH 7.4, 1 mM MgCl2, 0.25 mM CaCl2, PIC, 
200 g/mL PMSF, pepstatin 4 g/mL and DNase I. The tissue extracts were centrifuge at 
1,400 g for 10 min and the pellets were homogenized again in 4 ml buffer for 8 strokes 
and centrifuged again. Supernatants from the two homogenization steps were pooled, 
centrifuged at 750 g for 10 min. Aliquots of the resulting supernatants were used for gel 
filtration experiments. The remaining supernatants were diluted with equal volumes of 2 
pull-out buffer and then 2 volumes of 1 pull-out buffer containing 20 mM HEPEs/pH 
7.4, 1 mM MgCl2, PIC, 100 g/mL PMSF, 2 g/mL pepstatin, 0.2% triton X-100 and 
150 mM NaCl. Each sample was incubated with 5 mg M-270 Epoxy Dyanbeads, which 
were pre-coated with affinity purified polyclonal anti-GFP antibody, for 1.5 hours at 4C. 
Dynabeads were washed 5 times with 1 pull-out buffer and then incubated with 250 l 
elution buffer containing 0.5 mM EDTA and 0.5 M NH3·H2O for 20 min at room 
temperature. The eluents were collected, frozen in liquid nitrogen and dried in a 
Speedvac. The purified complexes were resolved on SDS-PAGE and stained with 
colloidal Coomassie. The entire gel lane of the Becn1–/–-; Becn1-EGFP/+ sample was 
sliced into ~30 2-mm wide pieces. Each gel piece was reduced, alkylated with 
iodoacetamide, and subject to in-gel digestion with trypsin. The resulting tryptic peptides 
were analyzed by MS and MS/MS, using either in-house-constructed MALDI-QqTOF 
and MALDI-ion trap (LCQ DECA XP; Thermo Electron Corporation) mass 
spectrometers or ESI-LTQ mass spectrometer (Thermo Electron Corporation). Accurate 
masses of the tryptic peptides and the masses of their product ions were used to identify 
proteins in each gel piece, using the computer search engines ProFound 
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(http://prowl.rockefeller.edu/prowl-cgi/profound.exe), Xproteo (http://www.xproteo.com) 
and GPM (http://prowl.rockefeller.edu/tandem/thegpm_tandem.html) to search the most 
up-to-date NCBI non-redundant mouse protein database. 
 
Plasmid constructs and stable cell lines 
Total RNA was extracted from postnatal day 12 mouse whole brain using RNeasy 
mini kit (Qiagen, USA). Full length cDNA was synthesized with Omniscript RT kit 
(Qiagen, USA) and used as templates for PCR amplifications with KOD HiFi DNA 
polymerase (Novagen, USA). Beclin1 was cloned into EcoRI and BamHI sites of 
pEGFP-N3 and pAs-Red vectors (Clonetech, USA). Atg14L was cloned into EcoRI and 
BamHI sites of pEGFP-N3, pAsRed and pCMV-FLAG (Sigma, St Louis, MO) vectors. 
Rubicon was cloned into HindIII and BamHI sites of pEGFP-N3, pAs-Red and pCMV-
FLAG2 vectors. UVRAG was cloned into XhoI and BamHI sites of pEGFP-N3 vector. 
Single or combinations of Beclin1 domains were cloned into EcoRI and BamHI sites of 
pCMV-FLAG2 vector. Truncated Atg14L mutants were cloned into EcoRI and BamHI 
sites of pEGFP-N3 vector. Truncated Rubicon mutants were cloned into KpnI and 
BamHI sites of pEGFP-N3 vector. EGFP-Atg12 and EGFP-Atg5 constructs were 
generously provided by Dr. X. Jiang. Myc-hVps34-hVps15-V5-His/pVITRO2 plasmid 
was described previously (Yan et al., 2008).  
 
Cell cultures and transfections 
Human embryonic kidney (HEK) 293 and 293T, Hela and NIH/3T3 cells were 
maintained in standard medium, i.e., Dulbecco’s modified Eagle’s medium (DMEM) 
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supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin 
(Invitrogen, Carlsbad, CA). MLE12 cells were generously provided by Dr. C Münz and 
maintained in DMEM/F12 medium (ATCC, Manassas, VA) supplemented with 0.005 
mg/ml insulin, 0.01 mg/ml transferrin, 30 nM sodium selenite, 10 nM hydrocortisone, 10 
nM beta-estradiol, 10 mM HEPEs, 2 mM L-glutamine, 2% FBS and 1% penicillin-
streptomycin. Transient DNA transfection was performed with standard calcium 
phosphate precipitation procedure, FuGene 6 or Lipofectamine 2000 kit, following the 
protocols provided by the manufacturers (Invitrogen, Carlsbad, CA). siRNA transfection 
of NIH/3T3 cells and GFP-LC3 MLE12 stable cells was performed with Lipofectamine 
RNAi MAX kit following the reverse transfection protocol provided by the manufacturer. 
The sequences of siRNAs are:  




Generation of stable cell lines 
HEK293 cells were transfected with pEGFP-N3 vector, Beclin 1-EGFP, Atg14L-
EGFP or Rubicon-EGFP, and were selected with 800 g/ml G418 for one week. Single 
colonies with EGFP expression were picked and culture was continued in medium 
supplemented with 200g/ml G418. Correct expression of EGFP-fusion protein was 
confirmed with western blot using anti-GFP antibody, after which cells were maintained 
in culture medium supplemented with 200g/ml G418. 
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In vitro protein immunoprecipitation (IP) 
DNA plasmids were transfected into HEK293T cells for IP. For Co-IP 
experiments, two or three plasmids were transfected simultaneously in equal amount. 
Cells were lysed in IP lysis buffer (20mM HEPES, pH7.4/ 1mM MgCl2/0.25mM mM 
CaCl2/ 0.2% Triton X-100/150mM NaCl/ protease inhibitor and PMSF-
pepstatin/DNaseI). For IP with anti-GFP, anti-Atg14L or anti-Rubicon antibody, 
Dynabeads M-270 E-proxy (Invitrogen, Carlsbad, CA) were conjugated with each 
antibody, and incubated with cell lysate at 4°C for 2 hours. After the beads were washed 
in IP lysis buffer for 5 times, proteins were eluted by incubating beads in elution buffer 
(0.5mM EDTA, pH8/0.5N NH3H2O) at room temperature for 20 minutes and dried with 
vacuum speed centrifuge. For FLAG-tagged protein IP, Anti-FLAG M2 affinity resin 
(Sigma, St Louis, MO) was used and the manufacture’s protocol was followed.  
 
Vps34kinase assay 
Vps34kinase assay was performed as described (Miled et al., 2007). Myc-
hVps34-hVps15-V5-His/pVITRO2 plasmid was transfected into HEK293T cells in 
combination with other FLAG-tagged or EGFP-tagged plasmids. Cells were lysed in 1% 
Nonidet P-40 lysis buffer (20 mM Tris/pH 7.5, supplemented with 137 mM NaCl, 1 mM 
MgC12, 1 mM CaC12, 100 mM NaF, 10 mM sodium pyrophosphate, 100 M Na3VO4, 
10% glycerol, and 0.35 mg/ml phenylmethylsulfonyl fluoride/protease and phosphatase 
inhibitors). Immunoprecipitation was performed with anti-myc affinity gel beads (Sigma, 
St Louis, MO), following manufacture’s protocol. Beads were washed in lysis buffer 
three times, followed by three washes in washing buffer (100 mM Tris-HCl/pH7.4 and 
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500 mM LiCl) and two washes in reaction buffer (10 mM Tri-HCl/pH7.4, 100 mM NaCl 
and 1 mM EDTA). Beads were re-suspended in 60 l of reaction buffer, followed by 
addition of 10 1 of 100 mM MnCl2 and 10 l of sonicated phosphatidylinositol (2 
g/l). The reaction was started by the addition of 10 l of 440 M ATP containing 10 
Ci of -32P-ATP, and beads were incubated for 10 min at room temperature. Reaction 
was terminated by adding 20l 8 M HCl, and organic phase was extracted with 160l 
chloroform:methanol (1:1). Extracted phospholipids products were resolved by thin layer 
chromatography (TLC) using a coated silica gel and a solvent composed of 
chloroform:methanol:H2O:ammonium hydroxide (v/v/v/v, 9:7:1.7:0.3), followed by 




Cultured cells were fixed in fresh 4% paraformaldihyde in 1x PBS, and 
permeablized in PBS with either 0.05%-0.1% Triton X-100 or 0.01% saponin for 10-30 
min at room temperature. After blocking in PBS containing 10% goat serum for 30 min-1 
h at room temperature, cells were incubated in primary antibodies overnight at 4°C. After 
three washes in PBS, cells were incubated with fluorescent secondary antibodies for one 
hour at room temperature, followed by four washes in PBS. Cells were mounted with 
fluorescence mounting medium and examined under Zeiss (Göttingen, Germany) upright 
and invert confocal microscopes. 
Brain sections were permeabilized in blocking buffer (10% goat serum and 0.1% 
Triton X-100 in PBS), and were incubated in primary antibodies diluted in blocking 
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buffer overnight at 4°C. Sections were then washed in PBS and incubated in Alexa Fluor 
conjugated secondary antibodies (Invitrogen) in PBS for 1 hour at room temperature. 
After washes in PBS, sections were mounted and examined in the same way as above. 
For HRP staining with paraffin sections, antigen retrieval was first performed and 
sections were incubated in 0.5% H2O2 for 15 minutes at room temperature to block the 
endogenous peroxidase activity. After permeabilization in the same blocking buffer as 
above, sections were incubated in primary antibodies diluted in blocking buffer overnight 
at 4°C. Vectastain Elite ABC Kit (Vector Laboratories) was used for secondary antibody 
reaction and signal detection following the manufacturer’s protocol. 
 
Electron microscopy  
 For morphology EM, transfected HEK293T cells were fixed in 2.5% 
glutaraldehyde (2.5GA) in 0.1M  cacodylate buffer, pH 7.4. Animals were perfusion 
fixed with 2% paraformaldehyde and 2% glutaraldehyde in 0.1M PB (pH7.4), and 200m 
sections were cut with vibrotme. After sample processing and embedding, 0.5 mm thin 
sections were cut and stained with 1% Toluidine Blue, and areas for further examination 
were selected under light microscope. Samples were then processed by routine 
transmission electron  microscopy procedure and embedded in Epon (Yue et al., 2002). 
For immuno-EM, transfected HEK293T cells were fixed in fresh PLP fixative 
(4% paraformaldehyde, 0.01M periodate, 0.075M lysine, and 0.075M phosphate 
buffer/pH7.4) supplemented with 0.05% glutaraldehyde for one hour. After three washes 
in PBS, cells were permeabilized with 0.01% saponin in PBS supplemented with 0.1% 
BSA for 15 minutes at room temperature, and were incubated with primary antibody 
 142
(anti-GFP) diluted in the same buffer overnight at 4°C. Vectastain Elite ABC kit was 
used for secondary antibody reaction, and cells were fixed again in 1.5% glutaraldehyde 
in 0.1 M cacodylate buffer supplemented with 5% sucrose. After three washes with 50 
mM Tris/pH 7.4 supplemented with 7.5% sucrose, DAB reaction was performed with the 
same kit. The reaction was stopped with 50 mM Tris/pH 7.4 supplemented with 7.5% 
sucrose, and cells were processed for silver enhancement as described (Teclemariam-
Mesbah et al., 1997). 
Sample blocks were cut with a diamond knife on a Leica UltracutE and ultra-thin 
(~70 nm) sections were collected on uncoated 200-mesh grids and stained with Uranium 
and Lead. Grids were viewed with a TecnaiSpiritBT Transmissiiom Electron Microscope 
(FEI) at 80 KV and pictures were taken with Gatan 895 ULTRASCAN Digital Camera. 




Liver and brain extracts from both beclin 1 +/– and beclin 1 –/–; beclin 1-GFP/+ 
mice at 4 month of age were prepared as described above. Cell extracts were prepared as 
previously described (Wang et al., 2006).  Tissue and cell extracts were diluted with 
equal volumes of 2 pull-out buffer (see above) and incubated for 15 min at 4C. The 
samples were then subject to ultracentrifugation at 100,000 g and the resulting 
supernatants were used for gel filtration experiments. Superdex 200 HR10/30 column 
(Pharmacia) was equilibrated with 2 bed volumes of filtered running buffer containing 20 
mM HEPEs/pH 7.4, 1 mM MgCl2, 500 g/mL PMSF, 1 g/mL pepstatin and 150 mM 
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NaCl. The column was calibrated using Biorad gel filtration calibrant mixture, which are 
composed of thyroglobulin (670 kDa), -globulin (158 kDa), ovalbumin (44 kDa), 
myoglobin (17 kDa) and vitamin B12 (1,350 Da). A spike of these calibrants (10 l) was 
also added to each sample (240 l) as internal calibrants. Both calibrants and samples 
were run at a flow rate of 0.2 ml/min. For each run, 2 bed volumes of buffer were used to 
elute the sample and a total of 80 fractions were collected 25-29 min after starting the 
runs and at a rate of 1 fraction/min. Two bed volumes of buffer were used to wash the 
column at the same flow rate in between two runs.  
 
Long-lived protein degradation assay 
       Long-lived protein degradation was accessed as described (Gronostajski and 
Pardee, 1984). In brief, NIH/3T3 cells were transfected with either control or Atg14L 
siRNA and plated in 12-well plates. After 48 h, standard medium was changed to leucine-
free medium supplemented with 1 Ci/ml 3H-L-leucine. After being pulse-labeled for 24 
h, cells were washed 3 times and further cultured in standard medium supplemented with 
excess unlabeled leucine (5 mM) for 16 h to chase out short-lived proteins. Cells were 
then washed 3 times and further cultured for 4 h in standard medium, Earle’s Balanced 
Salt Solution (EBSS), or EBSS supplemented with 10 mM 3-MA, all containing 5 mM 
unlabeled leucine. Both media and cell lysate were subject to trichloroacetic acid (TCA) 
precipitation. Long-lived protein degradation was calculated as the ratio of TCA-soluble 




Construction of beclin 1 targeting vector 
Two shuttle vectors were used to generate the final vector for BAC modification. 
S351 contains the diphtheria toxin A-fragment gene (DT-A) for negative selection at 
gene targeting against random integration, and S385 contains the two loxP sites and the 
pGKneo cassette flanked by two FRT sites. An DNA fragment about 1000 base pair (bp) 
in size (box A1), starting from around 1060 bp upstream of start codon of beclin 1 gene 
to around 60 bp upstream of start codon, was PCR amplified using BAC DNA as 
template and inserted into AscI and EcoRV sites of S351. A DNA fragment about 500 bp 
(box A2) immediately downstream of box A1 (and containing the second exon of beclin 
1 gene) was PCR amplified and inserted into EcoRV and KpnI sites of S385. A third 
DNA fragment about 2000 bp (box B) immediately downstream of box A2 was 
subcloned into FseI and SmaI sites of S351 and was later used as short arm for 
homologous recombination in gene targeting. Another DNA fragment about 2000 bp 
(box C) downstream of box B was subcloned into XbaI site of S351, and was used for 
homologous recombination in the process of BAC modification. Finally all the elements 
in S385 were linearized with NotI and PmeI digestion and ligated into NotI and SwaI 
sites of S351, generating the complete shuttle vector for BAC modification. Through 
modification, the loxP-A2-FRT-pGKneo-FRT-loxP fragment was replaced into the BAC 
clone. After linearization with PI-SceI digestion, the BAC clone was used as the targeting 





Gene targeting and blastocyst injection 
Linearized targeting vector was electroporated into embryonic stem (ES) cells 
derived from C57BL/6J-Tyrc-2J/J mice, and selection was performed with G418 treatment. 
50 surviving clones were picked and genomic DNA was extracted, followed by digestion 
with BamHI. Southern blot was performed using a 500 bp DNA fragment downstream of 
box B (short arm of the targeting vector) as the probe. Clones that gave a 5700 bp band 
were picked as possible positive clones, while negative clones gave a 4000 bp band.  
Genomic DNA from selected positive clones was purified and digested with SwaI and 
BglII, and southern blot was performed with the same probe as above. Clones that gave a 
band of 5500 bp were confirmed to be true positive clones from correct homologous 
recombination, and were used for blastocyst injection. For southern blot, genomic DNA 
was digested with restriction enzymes and separated on agarose gels, followed by transfer 
to nylon membrane (NP0HYB0010, GE). Probe synthesis and hybridization was 
performed using Prime-It II random primer labeling kit (Stratagene), following the 
manufacturer’s manual.  
 
Mouse genotyping 
Chimera mice from blastocyst injection were crossed to wild type C57BL/6J mice, 
and pups with white coat color were tail clipped for genotyping. Genomic DNA was 
extracted as described above and was used for southern blot. For genotyping analyses 




Generation of conditional knockout mice 
Positive mice were first crossed to transgenic mice that express FLP recombinase 
under the control of a broad promoter ROSA26 to remove the PGK-neo cassette flanked 
by two FRT sites from the genome, and the deletion was confirmed with southern blot. 
For genotyping FLP mice, the following primers were used 
Forward: 5’-CTAATGTTGTGGGAAATTGGAGC-3’ 
Reverse: 5’-CTCGAGGATAACTTGTTTATTGC-3’ 
Beclin 1flox/+ mice were crossed to each other to generate beclin 1flox/flox mice. 
Meanwhile they were crossed with either Pcp2-Cre or EMX-Cre mice to generate beclin 
1flox/+; Cre/+ mice. Finally beclin 1flox/flox mice were crossed with beclin 1flox/+; Cre/+ mice 
to generate beclin 1flox/flox; Cre/+ mice, in which beclin 1 expression is specifically 
deleted in either cerebellar Purkinje cells (Pcp2-Cre) or cortical and hippocampal 




Preparation of brain slices  
Mice at different ages were put into anesthesia with intraperitoneal Nembutal 
injection at dose of 0.01ml/g body weight. Perfusion was performed with 4% 
paraformaldehyde in 0.1M phosphate buffer (pH7.4), and dissected brains were post 
fixed in the same fixative at 4°C for overnight. For floating sections, brains were 
embedded into 5% low melting agarose gel and 40m sections were cut with vibrotome 
(Vibrotome). For cryosections, brains were subjected to cryo-protection in 30% sucrose 
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at 4°C for overnight, and then were embedded into Neg-50 compound (Richard-Allan 
Scientific). 20m sections were cut with cryostat (Leica). For paraffin sections, brains 
were dehydrated in series of ethanol (70%, 80%, 90%, and 100%) for 30 minutes x 2, 
followed by incubation in Xylene for 3 days, and were embedded into wax. 10m 
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